1️⃣ Big Picture: What Pregnancy Does to the Mother

Keep this one sentence in your head:

Pregnancy = hyperdynamic, hypervolemic, mildly hypotensive, mildly alkalotic, hypercoagulable state with dilated vessels and increased O₂ demand.

Everything else is just details of that sentence.

2️⃣ Cardiovascular System — CORE 20%

🔹 Key Numbers (These get asked!)

• Blood volume: ↑ ~30%
• Plasma volume: ↑ ~45%
• RBC mass: ↑ 20–30% → dilutional “physiological anaemia”
• Cardiac output: ↑ ~40% (4.5 → 6 L/min)
• Stroke volume: ↑ 30%
• Heart rate: ↑ ~10% (e.g. 80 → 90 bpm)
• Systolic BP: ↓ ~5 mmHg
• Diastolic BP: ↓ ~10 mmHg (lowest ~24 weeks)
• BP-↓ (1st) → ↓↓ nadir (2nd) → ↑ back to baseline (3rd)
• Peripheral resistance: ↓

🔹 Why does this happen?

• Progesterone, nitric oxide, prostacyclin (PGI₂) → vasodilation → ↓ systemic vascular resistance.
• Placenta = low-resistance vascular bed → “sucks” blood → ↓ BP, ↑ CO.
• To maintain perfusion → body increases volume + HR + SV, so CO ↑.

🔹 Distribution of the extra CO at term

Extra ~1.5 L/min goes mainly to:

• Uterus ~400 ml/min
• Skin ~500 ml/min (heat loss)
• Kidneys ~300 ml/min
• Other organs ~300 ml/min

👉 High-yield idea: uterus + skin + kidneys take most of the extra cardiac output.

🔹 After delivery

• Placenta removed → CO falls
• Most change settles by 6 weeks, but full return can take months.

🔹 Supine hypotension (VERY EXAM-LOVING)

• In 3rd trimester, supine position → gravid uterus compresses IVC → ↓ venous return → ↓ CO → dizziness, collapse.
• Management: left lateral tilt.

3️⃣ Respiratory System — CORE 20%

🔹 Big functional picture

• Ventilation ↑ ~40%, driven by progesterone acting on respiratory centre.
• Oxygen consumption ↑ ~50 ml/min.

🔹 Key blood gas changes

• PaCO₂ falls to ~4.1 kPa → chronic mild respiratory alkalosis
• Kidneys compensate:
• HCO₃⁻ ↓ to ~19–20 mEq/L
• Na⁺ and osmolarity ↓ slightly

👉 EXAM LINE: Pregnancy = chronic compensated respiratory alkalosis.

🔹 Mechanical/volume changes

• Tidal volume: ↑ ~40%
• Respiratory rate: ≈ no change
• Residual volume: ↓ ~200 ml
• Total lung capacity: ↓ ~200 ml
• Vital capacity: unchanged (~3.5 L)
• Bronchial smooth muscle: relaxed → ↓ airway resistance (progesterone)

🔹 Subjective dyspnoea

• ~70% of pregnant women feel breathless
• Combination of:
• Increased ventilation
• Mechanical restriction
• High O₂ demand
• But PaO₂ is fine or slightly ↑ → normal adaptation, not pathology (unless other red flags).

What CHANGES

🔻 Volumes that DECREASE

• Functional Residual Capacity (FRC) ↓ ~20%
• ↓ ERV (expiratory reserve volume)
• ↓ RV (residual volume)
• ↓TLC
• Reason: diaphragm elevation → less resting lung volume

👉 Clinical relevance:

• Less oxygen reserve → rapid desaturation during apnea (e.g., induction for LSCS)

🔺 Volumes that INCREASE

• Tidal Volume (VT) ↑ 30–40%
• Minute Ventilation ↑ (driven by ↑ VT, not RR)
• IRV

👉 Mechanism: progesterone → ↑ respiratory center sensitivity to CO₂

↔️ Volumes that stay ~NORMAL

• Vital Capacity (VC) ≈ unchanged

(↓ ERV offset by ↑ inspiratory capacity)

• Total Lung Capacity (TLC) ≈ unchanged or slight ↓

🔹 PE Risk

• Pregnancy is pro-thrombotic + venous stasis (IVC compression) → ↑ risk of pulmonary embolism.
• So any “sudden severe breathlessness + chest pain” ≠ just pregnancy dyspnoea.

4️⃣ Urinary System

🔹 Kidney and renal flow changes

• Kidney size: ↑ ~1 cm
• Renal blood flow: ↑ 50–60%
• GFR: ↑ 50–60% → 140–170 ml/min by term

👉 So the kidneys are hyperperfused + hyperfiltering.

🔹 Serum biochemistry (VERY HIGH-YIELD)

Because GFR ↑:

• Urea: falls (e.g. 4.3 → 3.1 mmol/L)
• Creatinine: falls (73 → 47 µmol/L)
• Urate and bicarbonate: also ↓
• Plasma osmolality: ↓

👉 EXAM PEARL:

A “normal” non-pregnant creatinine can be abnormally high in pregnancy.

So slightly raised creatinine in pregnancy = red flag.

🔹 Glycosuria & proteinuria

• Mild glycosuria & proteinuria are common/normal because filtered load ↑ and tubular reabsorption capacity is exceeded.
• But significant proteinuria → think pre-eclampsia etc.

🔹 Ureteric dilation

• Due to progesterone + mechanical compression → ureter dilatation
• Leads to urinary stasis → ↑ risk of UTI / pyelonephritis.

5️⃣ Gastrointestinal System — CORE 20%

🔹 Nausea & vomiting (early pregnancy)

• Due to ↑ hCG + progesterone.
• Mostly 1st trimester, often resolves later.

🔹 Motility & tone (progesterone is the star)

Progesterone causes smooth muscle relaxation →

• ↓ GI tone and motility
• Delayed gastric emptying
• Delayed intestinal transit → constipation
• Relaxed lower oesophageal sphincter → reflux/heartburn (very common)
• Gallbladder hypomotility (↓ CCK effect) → ↑ gallstone risk

🔹 Aspiration risk

• Slower gastric emptying + more acidic stomach content
• High risk of aspiration under general anaesthesia in labour.

🔹 Obstetric cholestasis (important clinical spot)

• Pregnancy-specific liver disorder
• Features:
• Intense itching (especially palms/soles)
• Raised LFTs + bile acids
• Risks: fetal distress, IUFD
• Likely due to abnormalities in bile acid transport (genetic + hormonal).

6️⃣ Haematological System — CORE 20%

🔹 Volume & “physiological anaemia”

• Plasma volume: ↑ 45%
• RBC mass: ↑ 20–30%
• Plasma expansion > RBC → Hb & Hct fall → “physiological anaemia of pregnancy”.

Typical values:

• Hb: ~13 → ~11.5 g/dL
• Hct: ~40% → ~34%

👉 Key: Anaemia in pregnancy is NOT always pathological, but you must rule out iron deficiency & thalassaemia trait.

🔹 WBCs and platelets

• Leucocytes: ↑ (especially neutrophils; up to 25,000/mm³ postpartum)
• Platelets: may drop up to 25% → gestational thrombocytopenia
• Platelet size ↑ (younger platelets)
• Usually mild, asymptomatic.

🔹 Iron

Extra iron requirements (~1000 mg total):

• 500 mg → maternal RBC mass
• 300 mg → fetus + placenta
• 200 mg → losses

Dietary absorption often insufficient → iron deficiency anaemia is the commonest haematological problem in pregnancy.

🔹 Coagulation: “Pregnancy = hypercoagulable”

• ↑ Factors VII, VIII, X, all factors increase
• factor 11,13 doesnt increase
• protein S ,Fibrionolysis,antithrobin 3,PAI decrease
• ↑ Fibrinogen → ESR doubles
• Fibrinolysis ↓ during pregnancy & labour → then rises after placenta delivery.
• Bleeding time/clotting time: usually normal.

👉 This gives a trade-off:

• Pros: protects against haemorrhage at delivery
• Cons: ↑ risk of DVT/PE.

7️⃣ Thyroid Physiology in Normal Pregnancy — Logic-Based Explanation

Pregnancy creates a state of increased thyroid hormone demand.

This occurs due to three primary physiological changes, each acting through a distinct mechanism.

1️⃣ hCG-Mediated Thyroid Stimulation

Cause

• Human chorionic gonadotrophin (hCG) rises markedly in early pregnancy (peaks in 1st trimester).

Why hCG affects the thyroid

• hCG and TSH are structurally similar.
• There is receptor homology between:
• TSH receptor
• LH/hCG receptor

👉 Because of this similarity, hCG has weak intrinsic TSH-like activity.

Mechanism

• Rising hCG → direct stimulation of the thyroid gland
• Increased thyroid hormone production (mainly T4)
• Negative feedback → suppression of pituitary TSH

Physiological Effects

• TSH levels fall in the first trimester
• The fall in TSH mirrors the rise in hCG (reciprocal relationship)
• Free T4:
• Remains within normal range
• Or slightly above normal in the 1st trimester

Timing

• hCG effect is confined to the first half of pregnancy
• As hCG falls later → TSH gradually rises back toward baseline

Pathological Extension

If hCG rises excessively:

• Hyperemesis gravidarum
• Trophoblastic tumours

→ hCG may reach levels sufficient to cause:

• Biochemical hyperthyroidism

2️⃣ Increased Urinary Iodine Loss

Cause

• Pregnancy → ↑ glomerular filtration rate (GFR)

Mechanism

• ↑ GFR → ↑ urinary iodide excretion
• Result → ↓ maternal plasma inorganic iodine concentration

Thyroid Compensation

To maintain euthyroidism, the thyroid:

• Increases iodine clearance from plasma
• Enlarges (thyroid hypertrophy)
• Increases hormone synthesis efficiency

Clinical Consequence

• Physiological thyroid enlargement in pregnancy
• Enlargement is more pronounced in iodine-deficient regions

3️⃣ Estrogen-Induced Rise in T4-Binding Globulin (TBG)

Cause

• Rising estrogen levels during pregnancy

Mechanism

• Estrogen:
• Increases hepatic synthesis of T4-binding globulin
• Reduces TBG degradation

Effects on Thyroid Hormones

• ↑ TBG → more T4 and T3 become protein-bound
• To maintain free hormone levels:
• Total hormone production increases

Laboratory Changes

• Total T4 and Total T3
• Increase between 6–12 weeks
• Stabilize by mid-gestation
• Free T4 / Free T3
• Remain within normal non-pregnant range
• Tend to fall by ~10–15% in late pregnancy

Integrated Hormonal Pattern Across Pregnancy

First Trimester

• ↑ hCG → thyroid stimulation
• ↓ TSH (physiological suppression)
• Free T4: normal or mildly elevated
• Total T4/T3: rising

Second & Third Trimesters

• hCG effect wanes
• TSH gradually rises but remains within normal range
• Free T4 slightly decreases late in pregnancy
• Total T4/T3 remain elevated due to high TBG

Overall Result: Increased Thyroid Hormone Demand

Because of:

• hCG stimulation
• Iodine loss
• Increased hormone binding (TBG)

👉 Pregnancy increases thyroid hormone requirements

Clinical Implication

• Women with pre-existing hypothyroidism:
• Require increased levothyroxine dosage
• To maintain a euthyroid state

Maternal–Fetal Thyroid Hormone Relationship

Early Fetal Life

• Fetal thyroid is non-functional initially
• Maternal thyroid supplies all thyroid hormone

Fetal Thyroid Development

• Fetal TSH and T4 detectable from ~10 weeks
• Before this → fetus is entirely dependent on maternal T4

Clinical Importance

• Maternal hypothyroidism → adverse fetal neurodevelopment
• Adequate maternal thyroid hormone is essential in early gestation

Fetal Surveillance

Indication

• Fetus at risk of thyroid dysfunction

Method

• Ultrasound surveillance

Target

• Detection of fetal goitre

Why it matters

• Fetal goitre can cause:
• Local airway compression
• Airway compromise at delivery

One-Line Integrated Summary

Pregnancy induces increased thyroid hormone demand through hCG-mediated stimulation, increased iodine loss, and estrogen-driven TBG elevation, leading to physiological TSH suppression in early pregnancy, higher total thyroid hormone levels, maintained free hormone levels, and a critical dependence of the fetus on maternal thyroid hormone in early gestation.

TRIMESTER-WISE ENDOCRINOLOGICAL CHANGES IN PREGNANCY — COMPLETE TABLE

Key

• ↑ = increased
• ↓ = decreased
• ↔ = unchanged
• CL = corpus luteum
• hPL = human placental lactogen
• CRH = corticotropin-releasing hormone
• ACTH = adrenocorticotropic hormone
• TBG = thyroxine-binding globulin
• CBG = cortisol-binding globulin

A. PITUITARY HORMONES

B. ADRENAL HORMONES (MATERNAL + FETAL CONTRIBUTION)

C. PLACENTAL HORMONES

D. METABOLIC / PANCREATIC HORMONES

E. THYROID HORMONES

ONE-LINE TRIMESTER THEMES (EXAM GOLD)

• 1st trimester → hCG-driven, insulin-sensitive, CL-dependent
• 2nd trimester → Placental takeover, rising insulin resistance
• 3rd trimester → Max insulin resistance, labour preparation, cortisol peak

ULTIMATE MEMORY LOCK

hCG → progesterone → hPL → estrogen → oxytocin

(maintenance → growth → metabolism → labour)

IMPLICATIONS OF MATERNAL PHYSIOLOGICAL CHANGES ON THERAPEUTIC DRUG ADMINISTRATION

1. Gastrointestinal changes → Absorption

• Gastric stasis + reduced gut motility → slower drug absorption.
• Lower gastric pH → alters ionization of some drugs → ↓ absorption for certain medications.
• Net effect: oral drug absorption may be impaired or delayed.

2. Plasma volume expansion → Distribution

• Pregnancy → ↑ plasma volume.
• ↑ Plasma volume → ↑ volume of distribution (Vd).
• Result → lower plasma drug concentrations than expected at standard doses.

Clinically important examples:

• Anticonvulsants → subtherapeutic levels → seizure risk.
• Thyroxine → inadequate replacement if dose not increased.

3. Renal changes → Excretion

• Pregnancy → ↑ renal plasma flow + ↑ GFR.
• Drugs mainly excreted by kidneys → faster clearance.
• Result → shorter half-life and lower steady-state levels.

4. Overall consequence

• Combined effects on absorption, distribution, and excretion →
• Dose adjustment is often required during pregnancy to maintain therapeutic levels.

PHYSIOLOGY OF LACTATION

A. BREAST DEVELOPMENT AND HORMONAL CONTROL

1. Breast development timing

• Structural breast development → puberty.
• Adult breast needs minimal hormonal stimulation to initiate milk secretion.

Key clinical point:

• 14 days of estrogen exposure + prolactin stimulation alone can initiate lactation

→ basis for inducing lactation in women adopting a baby.

2. Role of prolactin

• Prolactin = long-chain polypeptide hormone.
• Essential for milk synthesis.

3. Changes during pregnancy

• Early pregnancy:
• Alveolar cell hyperplasia
• Lactiferous duct proliferation
• Late pregnancy:
• Alveolar cell hypertrophy
• Initiation of secretory activity
• Stimulated by:
• ↑ Prolactin
• ↑ Human placental lactogen (hPL)

4. Why milk production is suppressed during pregnancy

• High estrogen + progesterone levels →Inhibit full milk secretion despite prolactin presence.

5. Post-delivery trigger

• After delivery:
• Rapid fall in estrogen and progesterone
• Inhibitory effect removed
• Full milk production begins

Clinical correlation:

• Estrogen intake during breastfeeding (e.g. combined OCP) → decrease breast milk production

B. COLOSTRUM AND MILK COMPOSITION CHANGES

1. Colostrum (early milk)

• High protein
• Low lactose

2. Changes over first 3 days postpartum

• Lactose concentration → rises sharply
• Protein concentration → falls

Important mechanism (often misunderstood):

• Protein fall is due to dilution, not reduced synthesis.
• To maintain ionic equilibrium:
• Water drawn into breast
• ↑ milk volume
• Total protein amount remains unchanged

C. MILK PRODUCTION QUANTITY AND REGULATION

1. Volume

• Average milk production: 500–1000 ml/day

2. Dependence on suckling

• Continued suckling →
• ↑ Prolactin release
• ↑ Oxytocin release
• Absence of suckling →
• Milk production declines
• May persist 3–4 weeks postpartum

3. Supply–demand equilibrium

• In breastfeeding mothers:
• Equilibrium reached by ~3 weeks
• Milk production matches infant demand
• Twin feeding → approximately double milk production

D. ENERGY REQUIREMENTS DURING LACTATION

1. Total requirement

• Breastfeeding woman requires ~2950 kcal/day

2. Recommended intake breakdown

• Baseline (nonpregnant, nonlactating): 2200 kcal
• Milk production requirement: +500 kcal
• Total recommended intake: 2700 kcal/day

3. Source of extra energy

• Additional ~250 kcal/day comes from:
• Maternal fat stores laid down during pregnancy

E. PROLACTIN REGULATION (NEUROENDOCRINE LOGIC)

1. Suckling → prolactin release

• Suckling →
• Afferent impulses → hypothalamus
• ↑ Prolactin secretion from anterior pituitary

2. Time course

• Peak prolactin: ~30 minutes after suckling
• Returns to baseline: ~120 minutes

3. Hypothalamic control

• Prolactin mainly controlled by inhibition, not stimulation.
• Dopamine = main prolactin inhibitory factor (PIF).

4. Drug effects

• Dopamine agonists (bromocriptine, cabergoline):
• ↑ Dopamine → ↓ Prolactin
• Used to suppress lactation
• Dopamine antagonists (metoclopramide):
• ↓ Dopamine action → ↑ Prolactin
• Used to stimulate milk production

5. Other regulators

• TRH may stimulate prolactin secretion.

6. Postpartum changes

• After 6 weeks postpartum:
• Basal prolactin levels decline
• Peak prolactin response declines
• Decline is slower with frequent and prolonged suckling

F. OXYTOCIN AND MILK EJECTION (LET-DOWN REFLEX)

1. Trigger

• Suckling →
• Afferent impulses →
• Hypothalamic supraoptic & paraventricular nuclei

2. Hormone synthesis and release

• Oxytocin synthesized in hypothalamus
• Released from posterior pituitary

3. Conditioning

• Oxytocin release can occur with:
• Baby crying
• Thinking about breastfeeding
• Release may begin before baby reaches breast

4. Pattern of release

• Released in short 1-minute bursts

5. Mechanism of action

• Oxytocin binds to myoepithelial cells:
• Surround alveoli
• Longitudinally arranged in milk ducts

Effects:

• Myoepithelial contraction →
• Milk forced into ducts
• Duct wall contraction →
• Duct dilation
• Easier milk flow to nipple

6. Functional summary

• Prolactin → milk production
• Oxytocin → milk ejection (let-down)

G. COMPOSITION OF BREAST MILK (LOGIC OVER FACTS)

1. Variability

• Varies:
• Between women
• Over time
• Within the same feed (early vs late milk)
• Most important determinant: time since birth

→ milk adapts to infant’s needs

2. Average composition (per 100 ml)

• Energy: 75 kcal
• Protein: 1.1 g
• Casein: 40%
• Whey: 60%
• Lactose: 6.8 g
• Fat: 4.5 g
• Sodium: 7 mmol
• Chloride: 11 mmol

H. MACRONUTRIENTS AND MICRONUTRIENTS

1. Carbohydrate

• Main carbohydrate: lactose
• Broken down by lactase →
• Glucose + galactose

2. Protein

• Human milk:
• 40% casein
• Cow’s milk:
• 80% casein
• Other proteins:
• Immunoglobulins
• Lactoferrin

3. Fat

• Mainly triglycerides
• Most variable component
• Carries vitamins A, D, E, K

Deficiencies:

• Vitamin D → rickets
• Vitamin K → haemorrhagic disease of newborn

4. Electrolytes

• Human milk has:
• ~⅓ sodium and chloride of cow’s milk
• Advantage:
• Lower solute load
• Less worsening of diarrhoea

5. Iron

• Very little iron in breast milk

Elaborative Clinical Scenario — Macronutrients & Micronutrients in Human Milk (Integrated, exam-oriented, zero omission)

Clinical Setting

3-month-old exclusively breastfed male infant is brought to the pediatric clinic by his mother with concerns about poor weight gain, frequent loose stools, and recent advice from relatives to “switch to cow’s milk for strength.”

The baby was born at term, normal delivery, no neonatal complications. The mother is healthy and breastfeeding on demand.

During counselling, the clinician explains why human milk is uniquely designed for the infant, linking each component to physiology, pathology, and clinical outcomes.

1. Carbohydrate — Lactose as the Core Energy Source

Human milk’s main carbohydrate is lactose.

• Lactose is broken down by intestinal lactase into:
• Glucose → immediate energy source for brain and tissues
• Galactose → critical for galactolipid synthesis, essential for myelination of the developing brain

Clinical relevance in this baby:

• The infant’s frequent stools are explained as normal for a breastfed infant:
• Lactose increases osmotic water content
• Supports healthy gut flora (lactobacilli)
• Switching to cow’s milk would:
• Increase solute load
• Risk osmotic diarrhoea and dehydration

👉 Key teaching point: Lactose supports brain development + gut health, not just calories.

2. Protein — Low Casein, High Whey = Easy Digestion + Immune Protection

Human milk protein composition

• 40% casein
• Predominantly whey proteins

Cow’s milk

• 80% casein
• Forms hard curds in the stomach

Clinical impact:

• Human milk proteins form soft curds → easier gastric emptying
• Reduces:
• Vomiting
• Constipation
• Feeding intolerance

Special protective proteins

• Immunoglobulins (especially IgA)

→ Coat gut mucosa → prevent pathogen adhesion

• Lactoferrin

→ Binds iron → deprives bacteria of iron → bacteriostatic effect

👉 In this infant:

• Despite frequent stools, there is no systemic illness
• Breast milk proteins are protective, not harmful

3. Fat — Energy, Brain Growth & Fat-Soluble Vitamins

Human milk fat is:

• Mainly triglycerides
• Most variable component (changes during a feed and over the day)

Physiological roles

• Major energy source
• Supplies essential fatty acids for:
• Brain development
• Retina development

Vitamin transport

Human milk fat carries:

• Vitamin A → vision, epithelial integrity
• Vitamin D → calcium absorption, bone mineralization
• Vitamin E → antioxidant protection
• Vitamin K → coagulation factor activation

Deficiency-linked clinical risks

• Vitamin D deficiency
• → Rickets
• Especially in:
• Dark-skinned infants
• Low sun exposure
• Vitamin K deficiency
• → Haemorrhagic disease of the newborn
• Prevented by vitamin K injection at birth

👉 Breastfeeding is ideal, but supplementation is still essential.

4. Electrolytes — Low Solute Load = Renal Safety

Human milk contains:

• ~⅓ the sodium and chloride of cow’s milk

Clinical advantages

• Lower renal solute load
• Immature neonatal kidneys are protected
• In diarrhoeal illness:
• Less osmotic worsening
• Reduced risk of hypernatremia

In this infant with loose stools:

• Breastfeeding should be continued, not stopped
• Cow’s milk would worsen dehydration risk

5. Iron — Low Quantity, High Bioavailability

Human milk contains:

• Very little iron

But:

• Bioavailability ~50%
• Compared to cow’s milk iron:
• Poor absorption
• Can cause occult gut blood loss

Clinical implication

• Term infants rely on prenatal iron stores for first ~6 months
• After 6 months:
• Iron-rich complementary feeding is essential
• Delayed weaning → risk of iron-deficiency anemia

👉 Low iron in breast milk is physiologically appropriate, not a flaw.

Final Integrated Clinical Message to the Mother

• Breast milk is:
• Easily digested
• Neuroprotective
• Immunoprotective
• Renal-safe
• Cow’s milk in infancy:
• ↑ casein load
• ↑ solute load
• ↑ diarrhoea risk
• ↑ renal stress
• Supplement vitamin D and ensure vitamin K at birth
• Introduce iron-rich complementary foods at 6 months

One-Line Examiner Summary

Human milk is uniquely tailored for infant physiology—providing optimal energy, immune protection, renal safety, and neurodevelopment despite low absolute iron and vitamin levels, which are compensated by high bioavailability and supplementation strategies.

I. IMMUNITY FROM BREAST MILK

1. Immunoglobulins

• Predominant Ig: IgA
• Smaller amounts: IgM, IgG

2. Function of IgA

• Poorly absorbed
• Remains in infant gut →
• Protects against infection

3. Enteromammary pathway

• Maternal gut exposure to pathogen →
• Plasma cells migrate from gut → breast
• Produce pathogen-specific IgA
• Secreted into milk → infant protection

4. Additional anti-infective factors

• Lysozyme
• Lactoferrin

5. Public health importance

• Crucial in areas with poor water sanitation
• Reduces diarrhoeal mortality
• Major advantage over formula feeding

J. CONTRACEPTIVE EFFECT OF BREASTFEEDING

1. Hormonal effect

• High prolactin →
• Suppresses ovulation
• Causes lactational amenorrhoea

2. Limitations

• Not a reliable contraceptive
• After 1 year of exclusive breastfeeding:
• 10% of women conceive without other contraception

3. Population impact

• In developing countries:
• Breastfeeding prevents more pregnancies than all other contraceptive methods combined

• CVS:
• ↑ CO (40%), ↑ blood volume, ↓ BP, ↓ SVR, supine hypotension from IVC compression.
• Resp:
• ↑ tidal volume, ↑ ventilation, PaCO₂ ~4.1 kPa, chronic compensated respiratory alkalosis, O₂ consumption ↑.
• Renal:
• ↑ RBF & GFR (50–60%), ↓ urea, creatinine, osmolality, mild glycosuria & proteinuria, dilated ureters → ↑ UTI risk.
• GI:
• Progesterone = ↓ motility, reflux, constipation, gallstones; obstetric cholestasis = itching + raised bile acids.
• Haematology:
• Physiological dilutional anaemia, hypercoagulable state, ↑ fibrinogen, ↑ factors VII/VIII/X, ↑ WBC, mild ↓ platelets.

ONSET OF LABOUR, MYOMETRIAL CONTRACTILITY & CERVICAL DILATATION

(Logic-based physiological sequence)

I. WHY THE UTERUS STAYS QUIET DURING PREGNANCY (MYOMETRIAL QUIESCENCE)

Core Problem:

The uterus is massively stretched but does not contract → this requires active suppression.

Key Maintainer: Progesterone

How progesterone enforces quiescence:

1. ↓ Myometrial gap junction formation

→ cells cannot electrically synchronize

→ contractions remain weak & uncoordinated

2. ↓ Effect of interleukin-8 (IL-8)

→ delays cervical ripening

3. ↓ Uterine sensitivity to oxytocin

→ oxytocin present, but uterus does not respond strongly

Supporting contributors:

• Catecholamines → relax uterine muscle
• Relaxin → contributes to uterine relaxation

Evidence of progesterone dominance:

• Antiprogesterones (e.g. mifepristone):
• Cause cervical ripening
• Increase myometrial contractility

➡️ Conclusion: Pregnancy is an actively maintained “anti-labour” state.

II. CHANGES THAT PRIME THE UTERUS FOR LABOUR (THIRD TRIMESTER)

Labour is prepared gradually, not triggered suddenly.

A. ESTROGEN RISE (ESTRADIOL)

Estradiol reverses progesterone effects:

1. ↑ Oxytocin receptors in myometrium

→ uterus becomes responsive

2. ↑ Oxytocin synthesis within uterus
3. ↑ Formation of myometrial gap junctions

→ coordinated uterine contractions become possible

B. CORTICOTROPHIN-RELEASING HORMONE (CRH)

CRH acts as a central coordinator:

1. ↑ Prostaglandin synthesis
2. Direct stimulation of myometrial contractility
3. ↑ Inflammatory mediators:
• Interleukin-1β
• Interleukin-8
• COX-2

➡️ Labour begins to resemble an inflammatory process

C. GAP JUNCTION ACCUMULATION

• Gap junctions = electrical + chemical communication channels
• Allow wave-like uterine contractions
• Estrogen promotes their formation

➡️ This explains synchronised fundal dominance contractions

III. WHAT ACTUALLY TRIGGERS LABOUR? (UNRESOLVED QUESTION)

Progesterone withdrawal?

• Occurs in sheep
• Does NOT occur systemically in humans

Human hypothesis: Functional progesterone withdrawal

Possible mechanisms:

1. Local withdrawal (fetal membranes)
2. Progesterone receptor switch:
• From PR-A (type 1) → PR-B (type 2) near term

➡️ Progesterone present, but effectively inactive

IV. ROLE OF OXYTOCIN — IMPORTANT BUT NOT THE TRIGGER

Key observations:

• No significant rise in maternal oxytocin before or during labour
• Marked rise in oxytocin receptors near term

Interpretation:

• Oxytocin amplifies labour
• It does not initiate labour

Fetal oxytocin:

• Umbilical artery level = twice venous
• Role uncertain

V. FETAL CONTRIBUTION TO LABOUR ONSET

Fetal cortisol hypothesis:

1. Fetal cortisol ↑
2. ↑ Placental CRH synthesis
3. ↑ Prostaglandins & inflammatory mediators
4. Labour promoted

➡️ Suggests labour may be feto-placentally driven

VI. INFLAMMATORY CASCADE AT LABOUR ONSET

At labour onset:

• Rapid ↑ COX-2 activity
• Rapid ↑ cytokines

Prostaglandin sources:

Clinical correlation:

• COX inhibitors (e.g. indometacin) → used in preterm labour tocolysis

➡️ Labour behaves like a controlled inflammatory process

VII. PROSTAGLANDINS — DUAL ROLE

A. Myometrium (Uterine body)

• Prostaglandins → powerful uterine contractions

B. Cervix (Cervical ripening)

Under influence of:

• Prostaglandins
• Interleukin-8
• Estrogen
• Possibly relaxin

Mechanism:

1. Neutrophils migrate into cervix
2. Release collagenase
3. Collagen breakdown
4. Cervix becomes:
• Soft
• Stretchy
• Dilatable

➡️ This = cervical ripening

VIII. CELLULAR BASIS OF MYOMETRIAL CONTRACTION

Core mechanism:

• Actin–myosin interaction
• Controlled by calcium-dependent myosin-light-chain kinase

Importance of calcium:

• ↑ Intracellular Ca²⁺ → contraction
• ↓ Ca²⁺ → relaxation

IX. DRUGS THAT RELAX THE UTERUS (TOCOLYSIS LOGIC)

All work by reducing calcium availability

➡️ Once labour starts, feedback loops amplify prostaglandins & cytokines (poorly understood)

THIRD STAGE OF LABOUR

Definition:

Time from delivery of baby → delivery of placenta & membranes

Events:

1. Strong sustained uterine contraction
2. ↓ Placental bed surface area
3. Placenta shears off
4. Bleeding controlled by vessel compression

Hormonal control:

• Prostaglandin-F2α plays major role
• Oxytocin levels do NOT rise significantly

Clinical relevance:

• Carboprost, misoprostol mimic this → used in PPH

UTERINE INVOLUTION (POSTPARTUM RECOVERY)

Weight changes:

What decreases proportionally:

• Water
• Muscle
• Protein
• Collagen

Cause:

• Rapid withdrawal of placental hormones

ENDOMETRIAL REGENERATION & LOCHIA

Decidua:

• Day 3 postpartum → superficial decidua necrotic
• Shed with lochia

Endometrium:

• New lining in 1 week
• Placental bed coverage takes ~3 weeks

Lochia progression (3–6 weeks):

1. Lochia rubra → red
2. Lochia serosa → pink
3. Lochia alba → yellow-white

FINAL INTEGRATED LOGIC

Pregnancy: Progesterone-dominated quiescence

Late pregnancy: Estrogen + CRH prime uterus

Labour onset: Inflammatory prostaglandin cascade

Labour maintenance: Calcium-dependent myometrial contraction

Third stage: Prostaglandin-driven uterine retraction

Postpartum: Hormone withdrawal → involution + regeneration

🔥 Ultra-Short 1-Minute Revision (Guaranteed 80% Marks)

• Pregnancy ↓ drug absorption, ↑ distribution, ↑ renal excretion.
• Prolactin = milk production; oxytocin = milk ejection.
• Estrogen/progesterone block milk until placenta delivery.
• Human milk has low sodium, low casein, highly available iron.
• IgA is the main immune protector.
• Suckling → ↑ prolactin (30 min peak) + ↑ oxytocin (instant bursts).
• Breastfeeding delays ovulation but is NOT contraception.

STAGES OF LABOUR — FETAL PART POSITION MAP

FIRST STAGE OF LABOUR

Onset of true labour → full cervical dilatation (10 cm)

🔹 Cervix

• Effaces and dilates from 0 → 10 cm

🔹 Fetal Head

• Engaging / descending/ transversely
• At pelvic inlet → mid-pelvis
• Usually occiput transverse → rotates anteriorly

🔹 Shoulders (Bi-acromial diameter)

• Above pelvic inlet
• NOT entered true pelvis

🔹 Trunk & Limbs

• Above inlet

📌 Key exam line:

During first stage, only the head is negotiating the pelvis.

SECOND STAGE OF LABOUR

Full dilatation → delivery of fetus

🔸 EARLY SECOND STAGE

Head

• Below ischial spines
• At pelvic floor
• Undergoes internal rotation

Shoulders

• Still above pelvic inlet
• Enter pelvis only after head is on perineum

🔸 LATE SECOND STAGE (CROWNING → HEAD DELIVERY)

Head

• Delivered
• Lies outside vulva
• Shows restitution (realigns with shoulders)

Shoulders (Bi-acromial diameter)

• Now entering true pelvis
• Usually in oblique diameter
• At pelvic inlet → mid-pelvis

📌 If restitution absent → shoulders NOT entered pelvis (shoulder dystocia)

🔸 AFTER RESTITUTION

Shoulders

• Anterior shoulder under pubic symphysis
• Posterior shoulder in hollow of sacrum
• At pelvic outlet

Trunk & Body

• Follow immediately after shoulders

THIRD STAGE OF LABOUR

Delivery of fetus → delivery of placenta

• Fetus completely outside
• Uterus contracts → placental separation

ONE-LOOK EXAM SUMMARY TABLE

ULTRA-HIGH-YIELD EXAM SENTENCES

• Restitution = shoulders have entered pelvis
• No restitution = shoulder dystocia
• Head negotiates pelvis first
• Management:
• Empty bladder by catheterization or use enema
• Compress bulge with vaginal fingers to relieve obstruction
• Rarely:
• Large enterocele can bulge into vagina and block descent
• Reduce hernia sac and contents gently

PHYSIOLOGICAL CHANGES IN BREASTS & SKIN DURING PREGNANCY

I. BREASTS

A. Early Pregnancy Changes (Hormonal Sensitivity Phase)

What happens

• Breast tenderness
• Paresthesias (tingling sensations)

Why it happens

• Rapid rise in estrogen and progesterone
• Increased vascularity
• Neural sensitivity of breast tissue

Clinical logic

• These are functional changes, not pathological
• Often one of the earliest signs of pregnancy

B. Second Month Onwards – Structural Growth Phase

Observed changes

• Increase in breast size
• Delicate superficial veins become visible
• Nipples:
• Larger
• More deeply pigmented
• More erectile

Mechanism

• Estrogen → ductal proliferation
• Progesterone → lobulo-alveolar development
• Increased blood flow → venous prominence
• Melanocyte stimulation → pigmentation

C. Colostrum Production (Preparatory Lactation Phase)

What happens

• Thick, yellowish fluid (colostrum) may be expressed
• Occurs after the first few months
• Can be expressed by gentle massage

Why

• Prolactin effect on mammary glands
• Colostrum = antibody-rich, protein-dense first milk

Clinical note

• Presence of colostrum = normal
• Absence does not predict poor lactation later

D. Areolar Changes

Observed

• Areolae:
• Broader
• Darker
• Small raised nodules on areolae → Glands of Montgomery

What are Montgomery glands

• Hypertrophied sebaceous glands

Purpose

• Lubricate nipple
• Protect during breastfeeding
• Antimicrobial role

E. Skin Stretching Effects on Breasts

If breast enlargement is significant

• Skin striae may develop (stretch marks)
• Similar mechanism to abdominal striae

F. Pathological Enlargement (Rare)

Condition

• Gigantomastia
• Excessive, pathological breast enlargement

Why it matters

• Pain
• Postural problems
• Skin breakdown

Management logic

• Postpartum bromocriptine → suppress prolactin
• Later surgical reduction if needed

G. Breast Size vs Milk Production (Critical Exam Concept)

Key fact

• Prepregnancy breast size ≠ milk volume

Why

• Milk production depends on:
• Hormonal response
• Glandular tissue function
• Neuro-hormonal reflexes
• Feeding frequency

II. SKIN CHANGES IN PREGNANCY

General Overview

• ≥ 89% of pregnant women show at least one physiological skin change
• Driven mainly by:
• Hormonal changes
• Mechanical stretching
• Increased blood flow
• Genetic predisposition

III. ABDOMINAL WALL

A. Striae Gravidarum (Stretch Marks)

When

• Begin after mid-pregnancy

Appearance

• Reddish, slightly depressed streaks initially
• Later become pale, silvery scars (striae alba)

Distribution (study of primiparas)

• Abdomen: 70%
• Breasts: 33%
• Hips & thighs: 41%

Risk factors

• Younger maternal age
• Family history
• High prepregnancy weight
• Excessive gestational weight gain

Etiology

• Unknown
• Likely combination of:
• Dermal collagen disruption
• Hormonal influence
• Mechanical stretching

Management logic

• Aloe vera gel
• Almond oil
• Reduce itching
• May slow progression (not guaranteed prevention)

B. Diastasis Recti

What happens

• Rectus abdominis muscles separate at midline

Why

• Abdominal wall cannot withstand uterine expansion

Consequences

• Weak anterior abdominal wall
• If severe:
• Anterior uterine wall covered only by:
• Skin
• Attenuated fascia
• Peritoneum
• Forms a ventral hernia

IV. HYPERPIGMENTATION

A. Prevalence & Pattern

• Occurs in up to 90% of women
• More marked in darker-skinned women

B. Specific Pigmentary Changes

1. Linea Nigra

• Linea alba darkens to brown-black
• Midline of anterior abdominal wall

2. Chloasma / Melasma Gravidarum

• Irregular brown patches on:
• Face
• Neck
• Known as “mask of pregnancy”

3. Other Areas

• Areolae
• Genital skin

C. Postpartum Course

• Pigmentation:
• Usually regresses
• May not disappear completely

Important association

• Oral contraceptives can cause similar pigmentation

D. Pathophysiology

Not fully understood, but involves:

• Increased melanocyte-stimulating hormone (MSH)
• Polypeptide similar to corticotropin
• Markedly elevated during pregnancy
• Estrogen and progesterone:
• Direct melanocyte-stimulating effects
• Genetic susceptibility

V. VASCULAR CHANGES

A. Vascular Spiders (Spider Angiomas)

Appearance

• Small red papules
• Central lesion with radiating vessels

Common sites

• Face
• Neck
• Upper chest
• Arms

Terminology

• Nevus
• Angioma
• Telangiectasia

B. Palmar Erythema

• Redness of palms
• Common during pregnancy

C. Clinical Significance

• Benign
• No pathological significance
• Disappear after pregnancy in most women

Cause

• Hyperestrogenemia

D. Increased Cutaneous Blood Flow

Purpose

• Heat dissipation
• Compensates for increased metabolic rate in pregnancy

VI. HAIR CHANGES

A. Normal Hair Cycle

1. Anagen – growth phase
2. Catagen – apoptosis-driven involution
3. Telogen – resting phase

B. Pregnancy Effects

• Anagen phase lengthens
• Hair shedding decreases → hair appears thicker

C. Postpartum Changes

• Increased telogen phase
• Leads to postpartum hair shedding

If excessive

• Called telogen effluvium

Key logic

• Physiological
• Self-limiting
• Not pathological in most women

FINAL INTEGRATION LOGIC

• Most breast and skin changes in pregnancy are:
• Hormone-driven
• Physiological
• Reversible
• Structural stretching + hormonal pigmentation + vascular changes act together
• Absence or presence of these changes does not predict pathology unless extreme

Metabolic Changes in Pregnancy — logic-based notes (section-by-section, zero-miss)

1) Why metabolism changes (big picture)

• Driver = rapid growth of fetus + placenta + expansion of maternal tissues/fluids.
• Goal = store energy early, then shift fuels later to spare glucose/amino acids for fetus.

A) Basal metabolic rate (BMR) + energy needs

What changes

• By 3rd trimester, maternal BMR rises ~20% vs nonpregnant.
• With twin pregnancy, BMR rises ~10% more (on top of the singleton rise).

How it’s expressed (extra kcal/day by trimester)

• 1st trimester: ~85 kcal/day
• 2nd trimester: ~285 kcal/day
• 3rd trimester: ~475 kcal/day

Key observation (important logic)

• Some studies show women accumulate fat mass despite increased total energy expenditure without significant increase in intake.
• Interpretation: pregnancy can produce more efficient energy storage (higher “storage efficiency”).

B) Weight gain: where it comes from

Main contributors (most of “normal” weight gain)

• Uterus + contents (fetus, placenta, amniotic fluid)
• Breasts
• Expanded blood volume
• Expanded extravascular extracellular fluid

Smaller contributor (but conceptually important)

• “Maternal reserves” from metabolic shifts:
• cellular water
• fat
• protein

Typical total weight gain

• Average ≈ 12.5 kg (27.5 lb) and is remarkably consistent across studies/time.

C) Water metabolism

What changes

• Pregnancy causes greater water retention.
• Plasma osmolality drops by ~10 mOsm/kg.

Mechanism (why the osmolality drops early)

• Early pregnancy “resets” osmotic thresholds:
• thirst threshold lower
• vasopressin (ADH) secretion threshold lower
• Relaxin and other hormones likely contribute.

Mother–fetus water gradient (logic)

• Maternal serum osmolality becomes lower than umbilical arterial osmolality.
• This favors water transport to fetus.

How much extra water is accrued (minimum estimate at term)

• Fetus + placenta + amniotic fluid water ≈ 3.5 L
• Maternal expansion (blood volume + uterus + breasts) ≈ 3.0 L
• Minimum extra water accrued ≈ 6.5 L (≈ 15 lb)

Edema late pregnancy (why ankle pitting happens)

• Pitting edema of ankles/legs is common, especially end of day.
• Fluid can be ~1 L or more.
• Mechanisms:
1. Increased venous pressure below uterus due to partial IVC occlusion (mechanical compression effect).
2. Reduced interstitial colloid osmotic pressure in normal pregnancy → promotes edema.

Body composition studies (what correlates with baby size)

• Total body water and fat mass progressively increase.
• These + starting weight + pregnancy weight gain correlate with neonatal birthweight.
• “Overnourished” women more likely to deliver oversized neonates, even if glucose tolerant.

D) Protein metabolism

Core idea

• Products of conception + uterus + maternal blood are protein-rich (more than fat/carb).

Total protein added in pregnancy (term)

• Fetus + placenta ≈ 4 kg, containing about 500 g protein (≈ half of total pregnancy protein increase).
• Remaining ~500 g protein goes into:
• uterus (contractile proteins)
• breasts (mainly glandular tissue)
• maternal blood (hemoglobin + plasma proteins)

Amino acid handling (mother → fetus)

• Fetal amino acid concentrations are higher than maternal.
• Achieved by facilitated transport across placenta.
• Placenta also participates in:
• protein synthesis
• oxidation
• transamination of some nonessential amino acids
• Transport varies:
• between individuals
• between different amino acids
• Example nuance: tyrosine is conditionally essential in the preterm neonate, but not in the fetus.

Maternal protein intake vs birthweight

• In well-nourished women, maternal protein intake does not appear to be a critical determinant of birthweight.
• But emerging data suggest many guidelines may be too low (extrapolated from nonpregnant adults).
• Estimated requirements:
• Early pregnancy: ~1.22 g/kg/day
• Late pregnancy: ~1.52 g/kg/day
• Compared to older recommendation around 0.88 g/kg/day.

E) Carbohydrate metabolism

Classic pattern in normal pregnancy

• Mild fasting hypoglycemia
• Postprandial hyperglycemia
• Hyperinsulinemia

What happens after an oral glucose meal (unique responses)

• Prolonged hyperglycemia
• Prolonged hyperinsulinemia
• Greater suppression of glucagon

Not due to faster insulin breakdown

• Insulin half-life is not appreciably changed in pregnancy.
• Therefore, pattern reflects peripheral insulin resistance.

Purpose (logic)

• Insulin resistance helps maintain a sustained postprandial glucose supply to fetus.

Degree of insulin resistance

• Late normal pregnancy insulin sensitivity is ~30–70% lower than nonpregnant.

Mechanisms (multi-factor)

• Endocrine + inflammatory factors, including:
• progesterone
• placentally derived growth hormone
• prolactin
• cortisol
• cytokines (e.g., TNF)
• adiposity-derived hormones, especially leptin (and its interplay with prolactin)

Not only insulin resistance

• Hepatic gluconeogenesis increases in both diabetic and nondiabetic pregnancies, especially 3rd trimester → also pushes postprandial glucose up.

Fasting physiology shift: “accelerated starvation”

• Overnight fasting: switch from postprandial state (higher sustained glucose) to fasting state with:
• lower plasma glucose
• lower some amino acids
• higher free fatty acids, triglycerides, cholesterol
• This shift from glucose → lipids as main maternal fuel is called accelerated starvation.
• With prolonged fasting, these changes become exaggerated and ketonemia develops rapidly.

F) Fat metabolism

What changes

• Plasma lipids, lipoproteins, apolipoproteins rise during pregnancy.

Why hyperlipidemia happens

• Driven mainly by:
• increased insulin resistance
• estrogen stimulation

Time course (anabolic → catabolic shift)

• 1st and 2nd trimesters: increased lipid synthesis + intake → fat accumulation.
• Overweight women with excessive gestational weight gain accrue more fat.
• 3rd trimester: fat storage declines/ceases because:
• lipolysis increases
• lipoprotein lipase activity decreases → less triglyceride uptake into adipose
• Logic of the shift:
• Maternal metabolism uses lipids for energy
• Spares glucose and amino acids for fetus

Striking late change (3rd trimester)

• Triacylglycerol and cholesterol levels rise in:
• VLDL
• LDL
• HDL
• After delivery: these levels decline.

Breastfeeding effects (lipids)

• Breastfeeding:
• lowers triglycerides
• raises HDL-C
• Effects on total cholesterol and LDL-C are unclear.

Vascular concern vs reality (endothelium)

• Hyperlipidemia is theoretically concerning (linked with endothelial dysfunction),
• But endothelium-dependent vasodilation improves across pregnancy, possibly because:
• increased HDL-C may inhibit LDL oxidation → endothelial protection
• Therefore, increased cardiovascular disease risk in multiparas may relate to factors other than just cholesterol.

G) Leptin

What it is + key roles (nonpregnant + pregnancy relevance)

• Peptide hormone mainly from adipose tissue in nonpregnant state.
• Roles include:
• fat/energy regulation
• reproduction
• implantation, cell proliferation, angiogenesis
• Deficiency: linked with anovulation and infertility
• Certain mutations: cause extreme obesity

Pregnancy pattern

• In normal-weight gravidas:
• leptin rises, peaks in 2nd trimester, then plateaus to term
• levels are 2–4× nonpregnant
• In obese women:
• leptin correlates with adiposity
• After delivery:
• leptin falls (reflects major placental production)

Leptin resistance (logic)

• Despite high leptin, sensitivity to leptin’s appetite/energy effects is reduced:
• “leptin resistance”
• Likely purpose: promotes energy storage during pregnancy and supports later lactation.

When high leptin becomes harmful (obesity-related)

• Leptin acts as a pro-inflammatory cytokine in white adipose tissue.
• May dysregulate inflammation → placental dysfunction in obese women.
• Associations: preeclampsia, gestational diabetes, fetal distress.

Fetal leptin (developmental importance)

• Supports development of organs including:
• pancreas, kidney, heart, brain
• Fetal leptin correlates with maternal BMI and birthweight.
• Low fetal leptin associated with fetal growth restriction.

H) Other adipocytokines

Adiponectin

• Produced mainly in maternal fat, not placenta.
• May help early pregnancy by assuring glycogen source for fetal energy.
• Levels inversely correlate with adiposity.
• Potent insulin sensitizer.
• Though lower in gestational diabetes, assays aren’t useful for predicting diabetes development.

Ghrelin

• Mainly from stomach in response to hunger.
• Works with leptin and other neuroendocrine factors in energy balance.
• Also expressed in placenta; likely roles in fetal growth and cell proliferation.

Visfatin

• Initially identified as a B-lymphocyte growth factor; mainly produced in adipose tissue.
• Proposed that elevated visfatin + leptin may impair uterine contractility → possible physiologic link to higher risk of dysfunctional labor with obesity.

I) Electrolyte & mineral metabolism

Sodium and potassium

• Retained during normal pregnancy:
• ~1000 mEq sodium
• ~300 mEq potassium
• GFR filtration of Na/K increases, but excretion stays about unchanged because:
• tubular reabsorption increases
• Despite increased total body stores, serum concentrations:
• are slightly diminished
• Why lower serum levels?
• Potassium: possibly dilution from expanded plasma volume
• Sodium: altered osmoregulation and lower AVP threshold → more free water retention → lower sodium

Calcium (total vs ionized)

• Total serum calcium decreases because:
• plasma albumin decreases → less protein-bound (nonionized) calcium
• Ionized calcium remains unchanged (key exam point)

Fetal calcium demand + maternal adaptation

• Fetus accrues ~30 g calcium by term
• ~80% deposited in 3rd trimester
• Maternal adaptation:
• intestinal calcium absorption doubles
• mediated partly by increased 1,25-dihydroxyvitamin D3
• vitamin D levels are about doubled
• Possible drivers:
• ~twofold rise in PTH-related peptide (PTHrP) produced by tissues including placenta
• Practical implication:
• adequate dietary calcium is important to avoid excessive maternal depletion
• especially important in pregnant adolescents still building bone
• Evidence gap:
• limited robust data to draw firm conclusions on routine calcium/vitamin D supplementation utility.

Magnesium

• Serum magnesium declines in pregnancy:
• both total and ionized magnesium are significantly lower than nonpregnant.

Phosphate + calcitonin

• Serum phosphate generally stays within nonpregnant range.
• Calcitonin is an important calcium/phosphate regulator, but its specific pregnancy importance is poorly understood.

Iodine (why requirements rise)

Reasons iodine needs increase:

1. Maternal T4 production rises to maintain euthyroid state and supply thyroid hormone to fetus before fetal thyroid function.
2. Fetal thyroid hormone production increases in the second half of pregnancy (iodine crosses placenta readily).
3. Renal iodine clearance increases:
• iodine GFR increases ~30–50% from early pregnancy.

Net result: higher dietary iodine requirement in normal gestation.

Placenta:

• can store iodine, but whether it protects fetus from low maternal intake is unknown.

Extremes matter:

• Very low or very high maternal iodine intake may affect childhood neurodevelopment.
• Excess iodine supplements have been linked to congenital hypothyroidism via thyroid autoregulation (Wolff–Chaikoff effect).

Other minerals + iron exception

• For most other minerals: pregnancy causes little change beyond retention amounts needed for growth.
• Important exception: iron requirement increases considerably (discussed later in the chapter).

Hematological Changes in Pregnancy — logic-based notes (section-by-section, zero-miss)

1) Blood volume

What changes (magnitude + timing)

• Normal pregnancy causes hypervolemia.
• Average blood volume is ~40–45% above nonpregnant after 32–34 weeks.
• Variation is wide:
• some women increase only modestly
• others nearly double blood volume

Fetus not strictly required

• Increased blood volume can occur even without a fetus (example: some cases of hydatidiform mole).

Likely stimulus + vascular adaptation

• Exact stimulus is unknown, but likely related to renin and prorenin → promotes sodium + water retention.
• At the same time, vascular plasticity adapts to accommodate the larger volume.

Why hypervolemia is useful (functions)

1. Meets metabolic demands of the enlarged uterus and its markedly hypertrophied vascular system.
2. Provides abundant nutrients/elements for the rapidly growing placenta + fetus.
3. Expanded intravascular volume protects mother (and fetus) against effects of impaired venous return in supine and erect positions.
4. Safeguards mother against adverse effects of blood loss during parturition.

Time course across pregnancy

• Begins in the 1st trimester.
• By 12 menstrual weeks, plasma volume expands ~15% vs pre-pregnancy.
• Blood volume rises:
• most rapidly in midtrimester
• more slowly in 3rd trimester
• plateaus in the last several weeks
• Expansion is more dramatic in twin pregnancies.

Plasma vs red cell mass changes

• During expansion, both increase:
• plasma volume increases
• erythrocyte mass increases
• Usually plasma increases more than RBC mass.
• RBC volume increase is still substantial: average ~450 mL.

Bone marrow + reticulocytes + EPO

• Moderate erythroid hyperplasia in bone marrow.
• Reticulocyte count rises slightly in normal pregnancy.
• These are very likely due to increased maternal plasma erythropoietin (EPO).

Hemodilution effects (Hb/Hct/viscosity)

• Because plasma expands so much:
• Hb concentration decreases slightly
• hematocrit decreases slightly
• whole blood viscosity decreases
• Typical Hb at term: ~12.5 g/dL
• In ~5%, Hb is <11.0 g/dL.
• Therefore:
• Hb <11.0 g/dL, especially late pregnancy, is considered abnormal
• usually indicates iron-deficiency anemia, not “just normal hypervolemia.”

2) Iron metabolism

Baseline iron stores (why women start lower)

• Total iron in normal adult women: ~2.0–2.5 g (≈ half of men).
• Most iron is in hemoglobin or myoglobin.
• Normal young women’s iron stores: ~300 mg.
• Lower iron in women is partly from menstrual blood loss, but not only that.

Hepcidin: the key regulator (and what pregnancy does)

• Hepcidin is a peptide hormone regulating systemic iron homeostasis.
• Hepcidin levels drop early in pregnancy.
• Lower hepcidin → increased iron absorption via ferroportin in enterocytes.
• Lower hepcidin also → increased iron transport to fetus via ferroportin in syncytiotrophoblast.

What changes hepcidin (important logic)

• Hepcidin rises with inflammation.
• Hepcidin drops with:
• iron deficiency
• increased levels of several hormones, including:
• testosterone
• estrogen
• vitamin D
• possibly prolactin

Total iron requirement in pregnancy (~1000 mg) and where it goes

Of ~1000 mg iron needed for a normal pregnancy:

• ~300 mg actively transferred to fetus + placenta
• ~200 mg lost through normal excretion routes, mainly GI tract
• these are obligatory losses
• occur even if mother is iron deficient
• Expanded maternal RBC volume (~450 mL) requires ~500 mg iron
• key conversion: 1 mL erythrocytes contains ~1.1 mg iron

Timing: demand rises late

• Most iron is used in the latter half of pregnancy.
• After midpregnancy, iron requirement becomes large:
• averages ~6–7 mg/day

Why supplementation matters (what happens without it)

• In most women, 6–7 mg/day cannot be met by stores + diet.
• If a nonanemic pregnant woman doesn’t receive iron supplementation:
• serum iron and ferritin fall after midpregnancy
• optimal rise in maternal RBC volume doesn’t occur
• Hb and Hct fall appreciably as plasma volume continues to rise

Fetal protection even with severe maternal deficiency

• Fetal red cell production is not impaired because placenta transfers iron even when maternal deficiency is marked.
• Extreme example described:
• maternal Hb 3 g/dL
• fetus Hb 16 g/dL
• Placental iron transport/regulation is complex.

Postpartum iron “recycling” concept

• Normal vaginal delivery blood loss: at least 500–600 mL.
• Therefore, not all extra maternal hemoglobin iron is “spent.”
• Excess hemoglobin iron after delivery becomes stored iron postpartum.

3) Immunological functions

Big picture

• Pregnancy is associated with suppression of multiple humoral and cell-mediated immune functions.
• Purpose: tolerate the fetus as a “foreign” semiallogeneic graft (antigens from maternal + paternal origin).
• The maternal–fetal tolerance mechanism remains a major unsolved medical problem.

Key players and “cross-talk”

• Tolerance involves immune adaptations + cross-talk among:
• maternal microbiome
• uterine decidua
• trophoblast

Microbiome shift concept

• Some uterine areas previously considered sterile are colonized with bacteria.
• Usually these microbes are thought to be commensal and provide:
• tolerizing
• protective roles
• Commensals may inhibit proliferation of certain pathogens.

Two highlighted immune adaptations

1. Special MHC molecules on trophoblast
• trophoblast expresses specific MHC patterns that promote tolerance/protection.
2. CD4 T-cell subpopulation shift
• immune balance shifts from T-helper 1 (T1) to T2-mediated immunity.
• anti-inflammatory component includes suppression of:
• T1 cells
• TC1 (T-cytotoxic 1) cells
• leads to lower secretion of:
• IL-2
• interferon-α
• TNF

Immunoglobulins in cervix, fetus, and milk

• Cervical mucus:
• peak IgA and IgG levels are significantly higher during pregnancy
• immunoglobulin-rich cervical mucus plug forms barrier to ascending infection
• Fetus:
• IgG transfer in 3rd trimester provides passive immunity in anticipation of birth
• Breast milk:
• immunoglobulins secreted during lactation augment neonatal defenses against infection

4) Leukocytes and lymphocytes

Leukocyte count pattern

• Normal WBC counts in pregnancy can be higher than nonpregnant.
• Upper values approach 15,000/μL.
• During labor and early puerperium:
• WBC can rise markedly to ≥25,000/μL.

Why it happens (proposed)

• Cause is unknown.
• Similar response occurs during/after strenuous exercise.
• Possibly due to “reappearance” of leukocytes previously shunted out of active circulation.

Lymphocyte distribution changes

• B lymphocyte numbers unchanged
• Absolute T lymphocyte numbers rise → creates a relative increase
• CD4:CD8 ratio does not change

5) Inflammatory markers (why interpretation is tricky)

Core warning

• Many inflammatory tests are not reliable in pregnancy because baseline physiology shifts them.

Examples

• Leukocyte alkaline phosphatase:
• elevated beginning early in pregnancy
• (normally used in evaluating myeloproliferative disorders)
• C-reactive protein (CRP):
• rises rapidly with trauma/inflammation
• median CRP levels in pregnancy and labor are higher than nonpregnant
• in nonlaboring gravidas: 95% ≤ 1.5 mg/dL
• gestational age does not affect serum CRP levels
• ESR:
• increased in normal pregnancy due to elevated:
• plasma globulins
• fibrinogen
• Complement C3 and C4:
• significantly rise in 2nd and 3rd trimesters
• Procalcitonin:
• low to undetectable in midpregnancy
• increases at end of 3rd trimester and through first few postpartum days
• rises with severe bacterial infections
• remains low in viral infections and nonspecific inflammatory disease
• but measured levels poorly predict overt or subclinical chorioamnionitis after PROM

6) Coagulation and fibrinolysis

Balanced “upshift” in both systems

• In normal pregnancy, both coagulation and fibrinolysis increase, but remain balanced to maintain hemostasis.
• Evidence of activation:
• increased concentrations of all clotting factors except XI and XIII

Thrombin generation

• Procoagulant trend:
• thrombin generation level and rate progressively increase through gestation.

Fibrinogen (Factor I): key quantitative shift

• Nonpregnant fibrinogen average: ~300 mg/dL (range 200–400).
• Pregnancy: fibrinogen rises ~50%.
• Late pregnancy average: ~450 mg/dL (range 300–600).
• This rise contributes greatly to the marked increase in ESR.

Factor XIII (fibrin-stabilizing factor)

• Factor XIII levels drop significantly as pregnancy advances.

Thromboelastography (TEG)

• Few studies describe normal pregnancy TEG changes (limited evidence base).

Fibrinolysis pathway + D-dimers

• End-product of coagulation = fibrin formation.
• Fibrinolysis removes excess fibrin:
• tPA converts plasminogen → plasmin
• plasmin breaks down fibrin → fibrin degradation products like D-dimers
• D-dimer levels are increased in pregnancy.

Net effect: procoagulant state

• Evidence suggests fibrinolytic activity is reduced in normal pregnancy (despite some conflicting data).
• Increased plasminogen partially counters this, but overall:
• pregnancy is a procoagulant state
• Amniotic fluid is a potent activator of coagulation.
• Purpose:
• ensure hemostatic control during pregnancy
• especially during delivery when blood loss is expected

7) Regulatory proteins (natural anticoagulants)

What they are + relevance

• Natural inhibitors include:
• protein C
• protein S
• antithrombin
• Inherited/acquired deficiencies (“thrombophilias”) account for many thromboembolic episodes during pregnancy.

Activated protein C system (mechanism)

• Activated protein C + cofactors protein S and factor V act as anticoagulants by neutralizing:
• factor Va
• factor VIIIa

Pregnancy changes causing APC resistance

• Resistance to activated protein C increases progressively due to:
• drop in free protein S
• higher factor VIII concentrations

Quantitative changes (given values)

• From 1st → 3rd trimester:
• activated protein C levels decline 2.4 → 1.9 U/mL
• free protein S declines 0.4 → 0.16 U/mL

Antithrombin changes (pregnancy → postpartum)

• Antithrombin levels:
• drop ~13% between midpregnancy and term
• fall ~30% from this baseline until 12 hours postpartum
• return to baseline by 72 hours postpartum

8) Platelets

Pattern across pregnancy + postpartum

• Average platelet count declines across pregnancy.
• Returns to normal nonpregnant values by 4–12 weeks postpartum.
• Platelet counts are lower in twin pregnancies.

Why platelets fall (multiple mechanisms)

1. Hemodilution (partial explanation)
2. Likely increased platelet consumption
• leads to higher proportion of younger, larger platelets
3. Mild rises in markers of platelet activation with gestational age
• drop postpartum
4. Splenic enlargement → element of “hypersplenism”
• sequestration and premature destruction of platelets

9) Spleen

How it changes

• By end of normal pregnancy, spleen enlarges up to 50% compared with 1st trimester.
• Another report: splenic size ~68% greater than nonpregnant controls.

Why it enlarges (uncertain)

• Cause unknown.
• May follow:
• increased blood volume
• and/or pregnancy hemodynamic changes

Cardiovascular system in pregnancy — logic-based notes (section-by-section, zero-miss)

1) Early hemodynamic changes (when it starts + what drives it)

Timing (very early)

• Changes in cardiac function are apparent within the first 8 weeks.
• Cardiac output (CO) increases as early as week 5.

Why CO rises that early (core logic)

• CO rise reflects:
• reduced systemic vascular resistance (SVR) (afterload falls)
• increased heart rate (HR)

Blood pressure changes very early

• Compared with prepregnancy, by 6–7 weeks from the LMP, the following are significantly lower:
• brachial systolic BP
• brachial diastolic BP
• central systolic BP

Heart rate pattern

• Resting pulse rises ~10 beats/min in pregnancy.
• HR rises significantly:
• 12 → 16 weeks
• 32 → 36 weeks

(seen in both normal-weight and overweight women)

Plasma volume → preload → atrial changes (cause chain)

• Between 10 and 20 weeks, plasma volume expansion begins → preload rises.
• Increased preload leads to:
• significantly larger left atrial volume
• increased left atrial ejection fraction

Big picture purpose

• Ventricular performance is influenced by:
• decreased SVR
• changes in pulsatile arterial flow
• Multiple factors together create altered hemodynamics that:
• meet fetal physiologic demands
• while maintaining maternal cardiovascular integrity
• Stroke volume changes in late pregnancy + posture effects are summarized in the referenced figure (not provided here).

2) Heart (position, imaging effects, ECG, sounds, murmurs, structure & remodeling)

A) Anatomical displacement (mechanical reason)

• As diaphragm elevates progressively:
• heart shifts left and upward
• rotates on its long axis
• Consequences:
• apex moves somewhat laterally
• chest radiographs show a larger cardiac silhouette

B) Pericardial effusion (benign, contributes to silhouette)

• Normal pregnancy often has some benign pericardial effusion.
• This can further enlarge the cardiac silhouette.
• Together, these changes make it difficult to precisely identify moderate cardiomegaly on plain radiographs.

C) ECG changes in normal pregnancy

• Most common: slight left-axis deviation (due to altered position).
• Other possible findings:
• Q waves in leads II, III, aVF
• flat or inverted T waves in III and V1–V3

D) Cardiac sounds (expected physiologic modifications)

1. Exaggerated splitting of S1 + increased loudness of both components
2. No definite changes in S2 aortic and pulmonary elements
3. A loud, easily heard S3

E) Murmurs in pregnancy (what’s heard and when)

• In most gravidas, a systolic murmur is intensified:
• during inspiration in some
• or with expiration in others
• Less often:
• a soft diastolic murmur may be noted transiently
• continuous murmurs from breast vasculature may be heard

F) Structural dimensions + function (why the heart “looks bigger” but works normally)

• Expanding plasma volume is reflected by enlarged cardiac end-systolic and end-diastolic dimensions.
• At the same time:
• septal thickness does not change
• ejection fraction does not change
• Why EF and septal thickness stay stable:
• dimensional changes are accompanied by substantive ventricular remodeling
• characterized by LV mass expansion ~30–35% near term

G) Remodeling concept (physiologic vs pathologic continuum)

• Nonpregnant heart remodels in response to stimuli (e.g., hypertension, exercise).
• Cardiac plasticity likely exists on a continuum:
• physiologic growth (exercise-like)
• pathologic hypertrophy (hypertension-like)

H) MRI-based timeline and reversibility

• Cardiac MRI showed LV mass grows significantly starting 26–30 weeks and continues until delivery.
• Remodeling is:
• concentric
• proportional to maternal size
• occurs in both normal and overweight women
• resolves within ~3 months postpartum

I) “Is pregnancy a high-output state?” (important nuance)

• Clinically, ventricular function in pregnancy is normal (eudynamic).
• Using Braunwald ventricular function graph logic:
• for given filling pressures, CO is appropriate → function is normal.
• Therefore, pregnancy is not a continuous “high-output” state.

J) Cardiac work and oxygen use (how the heart meets increased demand)

• Efficiency of cardiac work (CO × mean arterial pressure) rises ~25%.
• Increased myocardial oxygen consumption is achieved mainly by:
• increased coronary blood flow
• rather than increased oxygen extraction.

3) Cardiac output (posture, gestation, twins, labor, postpartum)

A) Resting CO pattern (lateral recumbent baseline)

• When measured at rest in the lateral recumbent position:
• CO increases significantly beginning early pregnancy
• continues to rise
• remains elevated for the remainder of pregnancy

B) Supine position (mechanism of CO drop)

• Large uterus compresses veins → ↓ venous return from lower body.
• It may also compress the aorta.
• Result:
• cardiac filling is limited
• CO decreases

C) Quantified benefit of left lateral position (MRI data)

• Rolling from back to left side increases CO:
• at 26–30 weeks: by ~20%
• at 32–34 weeks: by ~10%

D) Fetal oxygenation link (labor posture)

• Fetal oxygen saturation is ~10% higher if a laboring woman is lateral recumbent vs supine.

E) Standing effect

• On standing, CO falls to the same degree as in a nonpregnant woman.

F) Multifetal pregnancy (twins) effects

• Compared with singletons:
• maternal CO is increased further by almost another 20%
• Twin CO data:
• 1st trimester mean CO ~5.5 L/min
• this is >20% greater than postpartum values
• 2nd trimester ~6.3 L/min
• 3rd trimester ~6.3 L/min
• 2nd/3rd trimester rise is an additional ~15% compared with 1st trimester
• Increased preload in twins → larger:
• left atrial end-diastolic diameter
• left ventricular end-diastolic diameter
• Increased HR and inotropic contractility in twins implies:
• reduced cardiovascular reserve in multifetal gestations.

G) Labor and delivery

• First-stage labor: CO rises moderately
• Second-stage labor (vigorous expulsive efforts): CO increases appreciably more
• After delivery: pregnancy-induced CO increase is lost, timing depends on blood loss.

4) Hemodynamic function in late pregnancy (invasive measurements)

Study design

• Right-heart catheterization in 10 healthy nulliparas at:
• 35–38 weeks
• again 11–13 weeks postpartum

Late pregnancy findings (what changes)

• Expected increases:
• HR
• stroke volume
• cardiac output
• Significant decreases:
• systemic vascular resistance
• pulmonary vascular resistance
• colloid osmotic pressure

What does NOT change much

• Pulmonary capillary wedge pressure: no appreciable change
• Central venous pressure: no appreciable change

Key conclusion

• Although CO rises, LV function (stroke work index) remains similar to nonpregnant normal range.
• Restated: normal pregnancy is not a continuous “high-output” state.

5) Circulation and blood pressure (gestational pattern + posture + supine syndrome)

A) BP trajectory across gestation

• Arterial pressure declines to a nadir at 24–26 weeks, then rises thereafter.
• Diastolic pressure decreases more than systolic.

B) Posture effects on brachial BP

• Sitting brachial BP is lower than lateral recumbent supine.
• Systolic BP is lower in lateral positions compared with:
• flexed sitting
• supine positions

C) Supine hypotensive syndrome (≈10% of women)

• Supine great-vessel compression → significant arterial hypotension.
• Similar changes can also be seen with:
• hemorrhage
• spinal analgesia

D) Uterine vs brachial pressure (supine)

• When supine:
• uterine arterial pressure (and thus uterine blood flow) is significantly lower than brachial pressure.
• Evidence on whether this directly affects fetal heart rate patterns in uncomplicated low-risk pregnancies is conflicting.

E) Vascular compliance changes (before/after pregnancy)

• Studies show significant declines in:
• mean arterial pressure
• arterial stiffness

between prepregnant and postpartum time periods

• Suggests pregnancy confers a favorable effect on maternal cardiovascular remodeling.

6) Venous system changes (pressure, flow, consequences)

Nature of venous circulation in pregnancy

• Venous system becomes high-flow, low-resistance during pregnancy.

Pressures: arm vs leg (supine)

• Antecubital venous pressure: unchanged
• Femoral venous pressure in supine:
• rises steadily from ~8 mmHg early pregnancy
• to ~24 mmHg at term

Flow and stasis logic

• Leg venous blood flow is retarded except when lateral recumbent position is assumed.
• Cause of lower-limb stagnation late pregnancy:
• occlusion/compression of pelvic veins and IVC by enlarged uterus

Reversibility

• Elevated venous pressure returns to normal:
• when the woman lies on her side
• immediately after delivery

Clinical consequences

• Contributes to:
• dependent edema
• hemorrhoids
• varicose veins (legs and vulva)
• Predisposes to:
• DVT
• pulmonary embolism

7) Renin–angiotensin II–aldosterone (RAAS) and plasma volume

Role

• RAAS controls BP via sodium and water balance.

What increases in pregnancy

• All components show increased levels in normal pregnancy:
• renin produced by maternal kidney and placenta
• increased angiotensinogen (renin substrate) produced by:
• maternal liver
• fetal liver

Why angiotensinogen rises

• Partly due to increased estrogen production.
• Important for first-trimester BP maintenance.

Angiotensin II sensitivity (key physiologic “refractoriness”)

• Normotensive nulliparas become and remain refractory to pressor effects of infused angiotensin II.
• Those who later become hypertensive:
• develop this refractoriness
• then lose it
• Diminished vascular responsiveness to angiotensin II may be:
• progesterone-related
• and also blunted by PlGF (placental growth factor)

Placental delivery effect

• Normally, women lose acquired refractoriness to angiotensin II within 15–30 minutes after placental delivery.
• Large intramuscular progesterone in late labor delays this return of responsiveness.

8) Cardiac natriuretic peptides (ANP, BNP, NT-proBNP, ST2)

What triggers release

• Secreted by cardiomyocytes in response to chamber-wall stretch.

What they do (volume control)

• Regulate blood volume by causing:
• natriuresis
• diuresis
• vascular smooth-muscle relaxation

Clinical utility (pregnant and nonpregnant)

• BNP and NT-proBNP (and newer analytes like ST2) may help:
• screen for depressed LV systolic function
• determine chronic heart failure prognosis

Normal pregnancy levels

• Despite increased plasma volume, plasma ANP and BNP remain in the nonpregnant range.
• Median BNP values across pregnancy are stable, typically <20 pg/mL.

Pathology note: preeclampsia

• BNP can be elevated in severe preeclampsia, possibly due to cardiac strain from increased afterload.
• ANP-related physiologic adaptations likely participate in:
• extracellular fluid expansion
• elevated plasma aldosterone concentrations in normal pregnancy

9) Prostaglandins (PGE2, PGI2) and vascular tone

Overall role

• Elevated prostaglandin production in pregnancy likely has a central role in controlling:
• vascular tone
• BP
• sodium balance

Renal medullary PGE2

• Renal medullary prostaglandin E2 synthesis is markedly elevated in late pregnancy.
• Presumed natriuretic.

Prostacyclin (PGI2)

• Principal endothelial prostaglandin; levels rise in late pregnancy.
• PGI2 regulates:
• blood pressure
• platelet function
• Helps maintain vasodilation during pregnancy.
• PGI2 deficiency is associated with pathological vasoconstriction.

PGI2 : thromboxane ratio

• Ratio in maternal urine and blood may be an important indicator of preeclampsia pathogenesis.

10) Endothelin

What it is

• Pregnancy generates several endothelins (vasoconstricting peptides).

Endothelin-1 specifics

• Potent vasoconstrictor produced in:
• endothelial cells
• vascular smooth muscle cells
• Regulates local vasomotor tone.

What stimulates endothelin production

• angiotensin II
• arginine vasopressin
• thrombin

What endothelins stimulate in return

• secretion of:
• ANP
• aldosterone
• catecholamines

Sensitivity in normal pregnancy vs pathology

• Vascular sensitivity to endothelin-1 is not altered in normal pregnancy.
• Pathologically elevated endothelin may play a role in preeclampsia.

11) Nitric oxide (NO)

Core role

• Potent vasodilator released by endothelial cells.
• May modify vascular resistance during pregnancy.

Placental importance

• Important mediator of placental vascular tone and development.

Pathology link

• Abnormal NO synthesis has been linked to preeclampsia.

Respiratory tract in pregnancy — logic-based notes (section-by-section, zero-miss)

1) Anatomical changes (shape changes → volume effects → symptoms)

Diaphragm + thorax geometry

• Diaphragm rises ~4 cm during pregnancy.
• Subcostal angle widens noticeably.
• Transverse diameter of thoracic cage increases ~2 cm (thorax “widens”).
• Thoracic circumference increases ~6 cm.

Key consequence (why lung volumes still fall)

• Even though the chest expands, the increase is not enough to prevent reduced residual lung volumes caused by the elevated diaphragm.

“Paradox” (movement vs volume)

• Despite higher diaphragm position and reduced residual volumes:
• diaphragmatic excursion is greater in pregnancy.

Symptom

• Dyspnea is common.

2) Pulmonary function (volumes, ventilation, airway mechanics, comparisons)

A) Functional residual capacity (FRC) — the big volume change

• FRC decreases ~20–30% (≈ 400–700 mL) during pregnancy.

What FRC is made of (components) + how each changes

FRC = Expiratory reserve volume (ERV) + Residual volume (RV)

• ERV drops 15–20% (≈ 200–300 mL)
• RV decreases 20–25% (≈ 200–400 mL)

Time course + mechanism

• FRC and RV decline progressively across pregnancy due to diaphragm elevation.
• Significant reductions are observed by the 6th month.

B) Inspiratory capacity (IC) — rises

• Inspiratory capacity increases 5–10% (≈ 200–350 mL).
• Definition reminder (as per text): IC = maximum volume that can be inhaled from FRC.

C) Total lung capacity (TLC) — mostly stable

• TLC = FRC + inspiratory capacity
• TLC is:
• unchanged, or
• declines <5% at term

D) Respiratory rate vs tidal volume vs minute ventilation

• Respiratory rate is essentially unchanged.
• Tidal volume increases significantly as pregnancy advances.
• Resting minute ventilation increases significantly as pregnancy advances.

Reported values vs nonpregnant (numbers given)

• Mean tidal volumes reported: 0.66 to 0.8 L (as stated in text).
• Resting minute ventilations reported: 10.7 to 14.1 L/min.
• Both are significantly greater than nonpregnant women.

Why minute ventilation rises (multi-factor logic)

Elevated minute ventilation is caused by:

1. Enhanced respiratory drive primarily due to progesterone’s stimulatory action
2. Low expiratory reserve volume
3. Compensated respiratory alkalosis
4. Decreased plasma osmolality → can cause less respiratory depression

E) Airflow, compliance, resistance

• Peak expiratory flow rates rise progressively as gestation advances.
• Lung compliance is unaffected by pregnancy.
• Airway conductance increases and total pulmonary resistance decreases:
• possibly as a result of progesterone.

F) Capacities that don’t change much

• Maximum breathing capacity: not appreciably altered.
• Forced (timed) vital capacity: not appreciably altered.

G) Closing volume (uncertain)

• It is unclear whether the critical closing volume is higher in pregnancy.
• (Critical closing volume = lung volume at which airways in dependent lung regions begin to close during expiration.)

H) Singleton vs twins (pulmonary function)

• Pulmonary function with a singleton does not significantly differ from that with twins.

I) Why respiratory diseases can be more serious in pregnancy

• Greater oxygen requirements
• and perhaps increased critical closing volume

→ make respiratory diseases more serious.

J) Nasal physiology (objective vs subjective findings)

• In a study of 85 pregnant women:
• minimal cross-sectional area decreased between 1st and 3rd trimesters
• BUT subjective nasal congestion and total nasal resistance:
• did not differ significantly among trimesters
• and did not differ significantly compared with nonpregnant controls.

3) Oxygen delivery (supply > demand, but demand rises)

A) Ventilation vs oxygen needs

• Oxygen delivered into the lungs by increased tidal volume clearly exceeds the oxygen requirements imposed by pregnancy.

B) Oxygen-carrying and delivery systems also increase

During normal pregnancy:

• Total hemoglobin mass increases

→ total oxygen-carrying capacity rises.

• Cardiac output increases.

C) Consequence: A–V O₂ difference decreases

• Because delivery capacity rises, maternal arteriovenous oxygen difference diminishes.

D) Oxygen consumption (VO₂) increases — key numbers

• Pregnancy: ~20% increase in oxygen consumption.
• Multifetal gestations: ~10% higher than singleton pregnancies.
• Labor: oxygen consumption increases 40–60%.

4) Acid–base equilibrium (why pregnant women feel “air hunger,” and why it helps the fetus)

A) Physiologic dyspnea (important clinical framing)

• Increased awareness of desire to breathe is common even early in pregnancy.
• This may be interpreted as dyspnea and can mimic disease, even when none exists.
• Physiologic dyspnea should NOT interfere with normal physical activity.

B) The main mechanism (tidal volume → PaCO₂ ↓ → dyspnea)

• Increased tidal volume lowers blood PaCO₂ slightly.
• Paradoxically, this can cause dyspnea (air hunger sensation).

C) Hormonal driver (central control)

• Increased respiratory effort and the fall in PaCO₂ are induced largely by:
• progesterone (major)
• estrogen (lesser)
• Progesterone acts centrally:
• lowers the threshold
• raises the sensitivity of the chemoreflex response to CO₂.

D) Compensation: kidneys reduce bicarbonate

• To compensate for respiratory alkalosis:
• plasma bicarbonate drops from ~26 to ~22 mmol/L.

E) Blood pH and O₂ dissociation curve: left shift + offsetting right shift

• Blood pH increases only minimally, but:
• it shifts the oxygen dissociation curve to the left.
• Left shift effect:
• increases maternal Hb affinity for oxygen
• described here as the Bohr effect
• which reduces maternal oxygen-releasing capacity.

But this is offset because:

• slight pH rise also stimulates increased 2,3-DPG in maternal RBCs
• which shifts the curve back to the right.

F) Why the fetus benefits (two-way gas transfer logic)

• Reduced maternal PaCO₂ from hyperventilation:
• aids CO₂ (waste) transfer from fetus → mother
• while also aiding oxygen release to the fetus (via the combined curve-shift effects).

Urinary system in pregnancy — logic-based notes (section-by-section, zero-miss)

1) Kidney (core physiologic adaptation: “hyperfiltration + high flow early”)

A) Structural change

• Kidney size increases ~1.0 cm in pregnancy.

B) GFR + renal plasma flow: the early, big shifts

• Both GFR and renal plasma flow increase early in pregnancy.
• GFR timeline (very high-yield)
• Up to +25% by the 2nd week after conception
• ~+50% by the beginning of the 2nd trimester
• Renal plasma flow
• rises ~80% before the end of the 1st trimester
• then declines in late pregnancy
• but GFR stays elevated until term even while renal plasma flow falls late.

C) Why hyperfiltration happens (two principal factors)

1. Hypervolemia → hemodilution
• lowers plasma protein concentration and thus lowers oncotic pressure of plasma entering the glomerular microcirculation.
2. Renal plasma flow rises markedly
• boosts filtration by increasing renal perfusion.

D) Symptoms explained by physiology (GFR ↑ → urine output tendencies)

• Mainly due to elevated GFR:
• ~60% of nulliparas in 3rd trimester have urinary frequency
• ~80% have nocturia

E) Postpartum (puerperium): what persists and why

• Marked GFR persists on postpartum day 1
• mainly from reduced glomerular capillary oncotic pressure.
• The gestational hypervolemia + hemodilution are still evident on day 1
• and resolve by the 2nd week postpartum.

F) Relaxin mechanism (how hormones drive renal vasodilation)

• Studies suggest relaxin mediates ↑GFR and ↑renal blood flow.
• Relaxin effects:
• boosts renal nitric oxide (NO) production
• → renal vasodilation
• → lowered afferent and efferent arteriolar resistance
• → ↑renal blood flow and ↑GFR
• Relaxin may also:
• increase vascular gelatinase activity
• → renal vasodilation + glomerular hyperfiltration
• → reduced myogenic reactivity of small renal arteries

G) Maternal posture effects (late pregnancy: posture matters)

• Late pregnancy:
• sodium excretion rate supine ≈ < half that in lateral recumbent position.
• Posture effects on GFR and renal plasma flow:
• they vary (not a single fixed direction given).

H) “Unusual” excretory feature: nutrient loss

• Pregnancy causes remarkably higher urinary losses of some nutrients:
• amino acids
• water-soluble vitamins
• These are excreted in much greater amounts.

2) Renal function tests (why “normal” lab values shift in pregnancy)

A) Serum creatinine (pregnancy normal is lower)

• Mean nonpregnant serum creatinine ~0.7 mg/dL
• During normal pregnancy it declines to ~0.5 mg/dL
• Creatinine ≥0.9 mg/dL suggests underlying renal disease → warrants further evaluation.

B) Creatinine clearance (higher in pregnancy, but collection accuracy is critical)

• Creatinine clearance in pregnancy averages ~30% higher than the nonpregnant 100–115 mL/min range.
• Useful to estimate renal function only if urine collection is:
• complete
• accurately timed
• If not precise → results become misleading.

C) Diurnal urine pattern reversal → nocturia + dilute urine

• In daytime, pregnant women tend to accumulate water as dependent edema.
• When recumbent at night:
• they mobilize this fluid → diuresis
• This reverses the usual nonpregnant diurnal urinary flow pattern:
• causes nocturia
• urine becomes more dilute than in nonpregnant women.

D) Concentrating ability: a key clinical pitfall

• If a pregnant woman cannot excrete concentrated urine after withholding fluids for ~18 hours, it does not necessarily mean renal damage.
• Reason:
• kidneys may be functioning normally by excreting mobilized extracellular fluid of relatively low osmolality.

3) Urinalysis (what findings mean in pregnancy)

A) Glucosuria

• Glucosuria during pregnancy may be normal.
• Mechanism:
• increased GFR
• plus impaired tubular reabsorptive capacity for filtered glucose

→ explains most cases.

• Frequency:
• ~one sixth of pregnant women spill glucose in urine.
• Clinical note:
• sensitivity is low, but glucosuria may indicate gestational diabetes.
• Guidance difference (as stated):
• No U.S. guidelines direct practice based on urine glucosuria alone.
• In the UK, early oral glucose testing is considered if:
• an isolated 2+, or
• repetitive 1+ dipstick readings.

B) Hematuria

• Most often suggests urinary tract disease or infection (evaluation referenced elsewhere in the text).
• Also common after difficult labor and delivery
• due to trauma to bladder and urethra.

C) Proteinuria (pregnancy threshold differs)

• Nonpregnant definition:
• protein excretion >150 mg/day
• In pregnancy, due to:
• hyperfiltration
• possible reduced tubular reabsorption
• Significant proteinuria is usually considered once:
• ≥300 mg/day is reached.
• Normal pregnancy data (24-hour):
• mean 24-hour protein excretion across trimesters: 115 mg/day
• upper 95% confidence limit: 260 mg/day
• no significant trimester differences
• albumin excretion is minimal: 5–30 mg/day
• Proteinuria tends to increase with gestational age
• correlates with the peak in GFR.

4) Measuring urine protein (3 approaches + pitfalls + how to collect properly)

The 3 common methods

1. Dipstick (qualitative)
2. 24-hour collection (quantitative)
3. Spot urine albumin/creatinine or protein/creatinine ratio

A) Dipstick — main limitation

• Major problem: does not account for urine concentration/dilution.
• Example:
• with polyuria and very dilute urine,
• dipstick may be negative/trace even when true protein excretion is excessive.

B) 24-hour urine — why pregnancy makes it tricky

• Affected by urinary tract dilation (explained in ureter section).
• Dilated tract can cause errors due to:
• retention (hundreds of mL can remain in dilated tract)
• timing (retained urine may have formed hours before collection)

How to minimize pitfalls (the stepwise “proper collection” protocol)

1. Hydrate the patient
2. Position in lateral recumbency (the definitive nonobstructive posture) for 45–60 minutes
3. Ask her to void
• discard this specimen
4. Immediately after that void → start the 24-hour collection
5. During the final hour:
• place patient again in lateral recumbent position
• at the end of this hour, the final urine is added to the total collected volume.

C) Protein/creatinine ratio — pros + cons

• Advantages:
• quick data
• avoids collection errors
• Disadvantages:
• protein per unit creatinine over 24 hours is not constant
• “abnormal” thresholds vary
• Nomograms exist for uncomplicated pregnancies.
• Unreliable postpartum.

5) Ureters (mechanical compression + right-sided dominance + “kinks” clarification)

A) Why ureters dilate (timing + location)

• After uterus rises out of pelvis:
• it rests on ureters
• laterally displaces + compresses them at the pelvic brim
• Above this level:
• intraureteral tone increases
• → hydroureter + hydronephrosis can be impressive.

B) Right-sided predominance (numbers + mechanisms)

• Dilatation is greater on the right.
• Right-sided in 86% of women.

Why the asymmetry may occur:

1. Left ureter cushioning by the sigmoid colon
2. Dextrorotated uterus may compress the right ureter more
3. The right ovarian vein complex becomes markedly dilated in pregnancy
• lies obliquely over the right ureter
• may add compression → proximal dilatation
4. Progesterone likely adds an additional effect.

C) Evidence supporting hormonal contribution (but compression still key)

• In monkeys:
• ureteral dilatation continued after fetus removal if placenta left in situ.
• However, in humans:
• relatively abrupt onset at midpregnancy fits better with ureteral compression.

D) “Kinks” are usually not true obstruction (imaging logic)

• Ureter elongation accompanies distention → ureter forms curves.
• Some curves can appear sharply angulated.
• Term “kinks” is misleading because it implies obstruction.
• Often they are single/double curves that:
• look like acute angulation on radiograph taken in same plane,
• but a second view at right angles usually shows gentle curves.

E) Procedure risk note

• Despite these anatomic changes:
• complication rates with ureteroscopy in pregnant vs nonpregnant patients do not differ significantly.

6) Bladder (trigone remodeling + pressures + continence mechanics + near-term procedural implications)

A) Early pregnancy vs later

• Few significant anatomical changes before 12 weeks.
• After 12 weeks, due to:
• increased uterine size
• pelvic organ hyperemia
• hyperplasia of bladder muscle + connective tissue

→ trigone changes.

B) Trigone + mucosa changes

• Trigone becomes:
• elevated
• intraureteric margin thickened
• Continued to term:
• marked deepening and widening of trigone
• Bladder mucosa:
• essentially unchanged except:
• increased size and tortuosity of blood vessels.

C) Bladder pressure and continence adaptations (numbers)

• Bladder pressure in primigravidas:
• rises from 8 cm H₂O early pregnancy → 20 cm H₂O at term.
• To compensate for reduced bladder capacity:
• absolute urethral length increases 6.7 mm
• functional urethral length increases 4.8 mm
• Maximal intraurethral pressure:
• rises 70 → 93 cm H₂O
• helping continence be maintained.

D) Incontinence is still common + important differential

• At least half of women have some degree of urinary incontinence by 3rd trimester.
• Always consider this in the differential diagnosis of ruptured membranes.

E) Near term bladder base distortion (nulliparas + engagement)

• Near term, especially in nulliparas (presenting part often engages before labor):
• entire base of bladder is pushed ventral and cephalad
• normal convex surface becomes concave
• Consequences:
• diagnostic and therapeutic procedures become more difficult
• pressure from presenting part impairs blood + lymph drainage from bladder base
• area becomes edematous
• easily traumatized
• possibly more susceptible to infection

GASTROINTESTINAL TRACT CHANGES IN PREGNANCY

1. Anatomical Displacement of GI Organs

What happens

• As pregnancy progresses, the enlarging uterus pushes the stomach and intestines upward (cephalad displacement).

Logical consequences

• Normal anatomical landmarks change, so:
• Physical signs of abdominal diseases become atypical.
• Pain locations may be misleading.

Classic example

• Appendix
• Normally in right iliac fossa
• In pregnancy:
• Displaced upward and laterally
• May reach the right flank

Clinical implication

• Appendicitis pain may not localize to McBurney’s point
• Diagnosis can be delayed or missed

2. Pyrosis (Heartburn) in Pregnancy

Core symptom

• Pyrosis = heartburn
• Very common in pregnancy

Primary mechanism

• Reflux of acidic gastric contents into the lower esophagus

Why reflux increases (multi-factorial logic)

A. Lower esophageal sphincter (LES)

• LES tone is reduced
• → Easier backflow of acid

B. Pressure changes

• Intraesophageal pressure ↓
• Intragastric pressure ↑
• → Pressure gradient favors reflux

C. Esophageal motility

• Peristalsis changes:
• ↓ Wave speed
• ↓ Amplitude
• → Slower acid clearance

D. Stomach position

• Altered stomach position contributes, but is not the main cause

Net effect

• More acid reflux
• Slower clearance
• Persistent heartburn

3. Gastric Emptying and Aspiration Risk

Baseline pregnancy

• Gastric emptying time
• Essentially unchanged compared to non-pregnant women
• Fasting gastric volume at term
• No difference from non-pregnant controls

Situations where emptying is delayed

• At term
• During labor
• Especially after analgesics

→ Gastric emptying becomes significantly prolonged

Critical anesthetic implication

• Increased risk of:
• Regurgitation
• Aspiration
• Aspirated material may be:
• Food-laden
• Highly acidic gastric contents

Why this matters

• One of the major dangers of general anesthesia during delivery

4. Maternal Gut Microbiome

Observed findings

• Some studies report changes in maternal gut microbiome during pregnancy

Current limitations

• Vaginal and gut microbiome profiles:
• Are not clearly defined
• Their influence on pregnancy outcomes remains unclear

Exam takeaway

• Association observed
• Causation and clinical significance not yet established

5. Hemorrhoids in Pregnancy

Frequency

• Very common

Primary causes

1. Constipation
2. Elevated pressure in rectal veins
• Occurs below the level of the enlarged uterus

Pathophysiology

• Venous congestion + straining
• → Dilation of hemorrhoidal veins

LIVER CHANGES IN PREGNANCY

1. Liver Size and Blood Flow

Size

• Does NOT enlarge in normal pregnancy

Blood flow

• Hepatic arterial flow ↑
• Portal venous flow ↑
• Both increase substantively

Mechanical property

• Liver stiffness
• Increases from 2nd to 3rd trimester
• Returns to baseline postpartum

2. Liver Function Tests in Normal Pregnancy

Alkaline phosphatase (ALP)

• Almost doubles
• Major contributor:
• Heat-stable placental ALP isoenzymes
• Important: not a sign of liver disease

Enzymes that are slightly LOWER

• AST
• ALT
• γ-glutamyl transpeptidase (GGT)
• Bilirubin

3. Serum Proteins

Albumin

• Serum concentration declines
• Late pregnancy:
• ~ 3.0 g/dL
• Non-pregnant:
• ~ 4.3 g/dL

Why total albumin still increases

• Plasma volume expansion
• → Total body albumin content rises despite dilution

Globulins

• Slightly increased

4. Leucine Aminopeptidase (LAP)

What it is

• Proteolytic liver enzyme
• Elevated in liver disease

What happens in pregnancy

• Markedly increased
• Due to:
• Pregnancy-specific enzyme(s)
• Different substrate specificity

Special enzymatic activities

• Oxytocinase
• Vasopressinase

Rare but important consequence

• Can cause transient diabetes insipidus
• Due to vasopressin degradation

GALLBLADDER CHANGES IN PREGNANCY

1. Structural and Functional Changes

Gallbladder volume

• Increases by ~50%

Contractility

• Decreases

Net effect

• Increased residual volume
• Biliary stasis

2. Hormonal Mechanism

Role of progesterone

• Inhibits cholecystokinin-mediated smooth muscle contraction
• Cholecystokinin = primary regulator of gallbladder contraction

→ Gallbladder empties poorly

3. Gallstone Formation

Why stones are more common

1. Impaired emptying
2. Bile stasis
3. Increased cholesterol saturation of bile

Who is most affected

• Multiparous women

Epidemiology

• ~ 8% have:
• Gallbladder sludge
• Or gallstones

4. Bile Acids and Cholestasis

Serum bile acids

• Effects of pregnancy are not fully characterized

Important clinical fact

• Pregnancy has a long-recognized tendency to cause intrahepatic cholestasis
• Due to retained bile salts

Reference

• Cholestasis of pregnancy discussed separately (Chapter 58)

FINAL EXAM LOGIC SUMMARY

• Uterus displaces organs → alters pain localization
• Progesterone:
• ↓ LES tone → reflux
• ↓ gallbladder contraction → gallstones
• Labor + analgesia → delayed gastric emptying → aspiration risk
• ALP rises from placenta, not liver pathology
• Albumin dilution ≠ reduced synthesis
• Pregnancy-specific enzymes can degrade oxytocin & vasopressin

ENDOCRINE SYSTEM CHANGES IN PREGNANCY — LOGIC NOTE (SECTION BY SECTION, ZERO OMISSION)

1) PITUITARY GLAND

A. Size change + optic chiasm logic

• During normal pregnancy, the pituitary enlarges by ~135%.
• This expansion can compress the optic chiasma enough to reduce visual fields.
• Actual impaired vision from pregnancy-related pituitary enlargement is rare.
• When vision impairment occurs, it is usually due to macroadenomas.

B. Why the pituitary enlarges (cell-type logic)

• Enlargement is mainly from estrogen-stimulated hypertrophy + hyperplasia of lactotrophs.
• Maternal serum prolactin levels parallel this pituitary growth (because lactotrophs produce prolactin).
• Gonadotroph numbers decline.
• Corticotroph and thyrotroph populations remain constant.
• Somatotroph function is generally suppressed due to negative feedback from placental production of growth hormone.

C. Imaging timeline postpartum

• Peak pituitary size can reach 12 mm on MRI in the first days postpartum.
• The gland involutes rapidly and returns to normal size by 6 months postpartum.

D. Pituitary tumors and pregnancy

• Incidence of pituitary prolactinomas is not increased during pregnancy.
• If a pituitary tumor is already large before pregnancy (macroadenoma, defined as ≥10 mm), growth during pregnancy is more likely.

E. Is maternal pituitary essential for pregnancy?

• Maternal pituitary is not essential for pregnancy maintenance.
• Many women after hypophysectomy have:
• completed pregnancy successfully,
• entered spontaneous labor,
• while receiving compensatory glucocorticoids, thyroid hormone, and vasopressin.

F. Growth hormone (GH) shift: maternal → placental source

1) Early pregnancy (first trimester)

• GH is predominantly secreted from the maternal pituitary.
• Serum and amniotic fluid GH concentrations stay within the nonpregnant range.

2) When placental GH becomes detectable

• As early as 6 weeks’ gestation, placental GH is detectable.

3) Mid-pregnancy dominance

• By ~20 weeks, placenta becomes the principal source of GH secretion.

4) Maternal serum GH pattern (numbers + timing)

• Maternal serum GH rises slowly:
• ~3.5 ng/mL at 10 weeks
• plateaus ~14 ng/mL after 28 weeks

5) Amniotic fluid GH pattern

• Amniotic fluid GH peaks at 14–15 weeks
• then slowly declines
• reaching baseline after 36 weeks

G. Placental growth hormone specifics (structure, source, function)

1) Structural difference

• Placental GH differs from pituitary GH by 13 amino acid residues.

2) Source cell

• Secreted by syncytiotrophoblast.

3) Regulation/effects

• Regulation and physiologic effects are incompletely understood.
• It influences fetal growth via upregulation of IGF-1.
• But fetal growth still progresses even in complete absence of this hormone.
• So it’s not absolutely essential, but may act with placental lactogen to regulate fetal growth.

H. Prolactin: levels, timing, paradoxes, functions

1) Maternal plasma prolactin levels

• Rise markedly during normal pregnancy.
• At term: usually ~10-fold higher than nonpregnant levels.
• Term value ~150 ng/mL.

2) Post-delivery “paradox”

• Plasma prolactin levels drop after delivery even in breastfeeding women.

3) Early lactation pattern

• During early lactation, pulsatile bursts of prolactin secretion occur in response to suckling.

4) Core role

• Principal function: ensure lactation.

5) Breast effects early in pregnancy (cell biology logic)

• Initiates DNA synthesis and mitosis in:
• glandular epithelial cells
• presecretory alveolar cells of the breast
• Augments number of:
• estrogen receptors
• prolactin receptors

in these cells.

6) Milk production machinery

• Promotes mammary alveolar cell RNA synthesis
• Promotes galactopoiesis
• Promotes production of:
• casein
• lactalbumin
• lactose
• lipids

7) Human proof of necessity for lactation (but not pregnancy)

• A woman with isolated prolactin deficiency failed to lactate after two pregnancies.
• This establishes: prolactin is required for lactation, but not for pregnancy.

8) Additional maternal adaptation roles

• Prolactin has numerous physiologic roles supporting maternal adaptations to pregnancy.
• Presence of prolactin receptor in maternal pancreas suggests prolactin may mediate pancreatic adaptations to pregnancy.

9) Proposed disease link

• A possible role has been proposed for a prolactin fragment in genesis of peripartum cardiomyopathy.

I. Prolactin in amniotic fluid

1) Concentration range + timeline

• Prolactin is present in amniotic fluid in very high concentrations.
• Up to ~10,000 ng/mL at 20–26 weeks.
• Thereafter declines.
• Reaches nadir after 34 weeks.

2) Source

• Uterine decidua synthesizes amniotic fluid prolactin.

3) Function (unknown, with one suggestion)

• Exact function unknown.
• One suggestion: supports water transfer from fetus to maternal compartment to prevent fetal dehydration.

J. Posterior pituitary hormones: oxytocin + ADH (vasopressin)

1) What they are

• Oxytocin and antidiuretic hormone (ADH, vasopressin) are secreted from posterior pituitary.

2) Oxytocin system in pregnancy

• Complex mechanisms promote quiescence of oxytocin systems during pregnancy.

3) ADH levels in pregnancy

• ADH (vasopressin) levels do not change during pregnancy.

4) Osmolality gradient logic

• Maternal osmolality is slightly higher than fetal blood.
• This gradient favors water transport to the fetus.

2) THYROID GLAND

A. Maternal–fetal thyroid axis linkage

1) Maternal control pathway

• Maternal hypothalamus secretes TRH.
• TRH stimulates thyrotrope cells of anterior pituitary.
• Thyrotropes release TSH (thyrotropin).

2) TRH in pregnancy

• Maternal TRH levels do not rise during normal pregnancy.

3) Placental crossing

• TRH crosses the placenta.
• May stimulate fetal pituitary to secrete TSH.

B. TSH–hCG relationship (structure → function logic)

1) Structural similarity

• TSH and hCG are glycoproteins.
• Their α-subunits are identical.
• Their β-subunits are similar but differ in amino acid sequence.

2) Functional consequence

• Because of this similarity, hCG has intrinsic thyrotropic activity.
• High hCG levels stimulate the thyroid.

3) What happens to TSH in 1st trimester

• In >80% of pregnant women, TSH declines in the first trimester.
• Yet TSH usually remains within the normal range for nonpregnant women.

C. Thyroid hormone production and thyroid size

1) Production increase

• Thyroid boosts hormone production by 40–100% to meet maternal + fetal needs.

2) How it achieves this

• Moderate enlargement occurs due to:
• glandular hyperplasia
• increased vascularity

3) Volumes (numbers)

• Mean thyroid volume:
• ~12 mL in 1st trimester
• ~15 mL at term

4) Clinical rule

• Normal pregnancy does not usually cause significant thyromegaly.
• Any goiter warrants evaluation.

D. Thyroid-binding globulin (TBG) and total vs free hormone logic

1) TBG rise timing

• Early 1st trimester: TBG rises.
• Peaks (zenith) at ~20 weeks.
• Stabilizes at about double baseline for rest of pregnancy.

2) Why TBG increases (2 mechanisms)

• Increased hepatic synthesis due to estrogen stimulation.
• Decreased metabolism due to increased TBG sialylation and glycosylation.

3) Consequence for labs

• Higher TBG increases total serum T4 and total T3.
• But it does not affect physiologically important free T4 and free T3.

4) Detailed timing patterns

• Total T4 rises sharply starting between 6–9 weeks.
• Total T4 plateaus at 18 weeks.
• Free T4 rises only slightly.
• Free T4 peaks along with hCG, then returns to normal.

E. Variation between pregnant women

• T4/T3 secretion responses vary.
• About one-third of women show:
• relative hypothyroxinemia,
• preferential T3 secretion,
• higher (but normal) serum TSH.
• So thyroid adjustments during normal pregnancy vary considerably.

F. Fetal dependence on maternal T4 + fetal timeline

1) Maternal T4 crossing

• Fetus relies on maternal T4 crossing the placenta in small quantities to maintain normal fetal thyroid function.

2) Fetal thyroid development milestones

• Fetal thyroid begins concentrating iodine at 10–12 weeks.
• Fetal thyroid hormone synthesis/secretion driven by fetal pituitary TSH begins ~20 weeks.

3) At birth: maternal contribution

• ~30% of T4 in umbilical cord blood is of maternal origin.

G. Thyroid function tests: diagnostic traps

1) Common findings in otherwise normal pregnancies

• A substantial proportion show:
• subclinical hypothyroidism
• or isolated hypothyroxinemia

2) Treatment debate

• Effects/benefits of thyroxine replacement in these women are controversial.

3) Misdiagnosis risks

• Normal TSH suppression can lead to misdiagnosis of subclinical hyperthyroidism.
• Bigger concern: missing early hypothyroidism because TSH is suppressed.

4) Solution approach

• Gestational-age–specific TSH normal curves developed for:
• singleton pregnancies
• twin pregnancies

H. Metabolic status despite complex thyroid regulation

• These thyroid regulatory changes do not appear to alter maternal thyroid status by metabolic studies.
• Basal metabolic rate (BMR) rises progressively by up to 25% in normal pregnancy.
• Most increased oxygen consumption is attributable to fetal metabolic activity.
• If fetal body surface area is included with maternal area:
• predicted and observed BMR are similar to nonpregnant women.

I. Iodine status

1) Increased requirement

• Iodine requirements increase during normal pregnancy.

2) If intake is low/marginal

• Deficiency may present as:
• low T4
• higher TSH

3) Global reality

• More than one-third of the world’s population lives where iodine intake is marginal.
• Even in modernized countries, iodine deficiency is common.

4) Why fetus is at risk

• Early thyroid hormone exposure is essential for fetal nervous system development.

5) Severe deficiency impact

• Despite public-health iodine supplementation, severe deficiency causing cretinism affects >2 million people globally.

3) PARATHYROID GLANDS (CALCIUM–BONE–VIT D AXIS)

A. Calcitriol and absorption

• During pregnancy, calcitriol (active vitamin D) increases twofold.
• This enhances intestinal calcium absorption.

B. Bone turnover and maternal skeleton sourcing

• In a longitudinal study of 20 women:
• all bone turnover markers rose during pregnancy,
• and failed to return to baseline by 12 months postpartum.
• Conclusion: calcium needed for fetal growth and lactation may be drawn at least partly from maternal skeleton.

C. Net effect: fetal priority, maternal cost

• Bone turnover factors create a net yield favoring fetal skeletal formation at maternal expense.
• Therefore pregnancy is a vulnerable period for osteoporosis.

D. PTH control logic (triggers + actions)

1) What stimulates PTH release

• Acute or chronic decline in plasma calcium
• Acute drops in magnesium

2) What suppresses PTH

• Increased calcium
• Increased magnesium

3) What PTH does (3 organs, 2 outcomes)

• Bone resorption ↑
• Intestinal absorption ↑
• Kidney reabsorption ↑

→ Raises extracellular fluid calcium

→ Lowers phosphate levels

E. Fetal calcium requirement and maternal adaptation

1) Total fetal need

• Fetal skeleton mineralization needs ~30 g calcium, mainly in 3rd trimester.

2) Perspective

• This is only ~3% of maternal skeletal calcium, but still challenges maternal calcium balance.

3) Absorption numbers

• Maternal intestinal calcium absorption rises gradually to ~400 mg/day in 3rd trimester.

4) Mediator

• Increased absorption seems mediated by elevated maternal 1,25-dihydroxyvitamin D.

5) Key paradox

• This occurs despite decreased PTH in early pregnancy (even though PTH normally stimulates active vitamin D production in kidney).

6) PTH pattern across pregnancy

• PTH declines in 1st trimester
• then rises progressively through the remainder of pregnancy.

F. Why active vitamin D rises despite low early PTH

• Likely due to placental production of either:
• PTH
• or PTH-related protein (PTH-rP)

PTH-rP context

• Outside pregnancy/lactation: usually detectable only in women with hypercalcemia due to malignancy.
• During pregnancy: PTH-rP concentrations rise significantly.
• Synthesized in fetal tissues and maternal breasts.

G. Calcitonin

1) Source

• Secreted by C cells, mainly in perifollicular areas of thyroid gland.

2) Function

• Opposes PTH and vitamin D actions.
• Protects maternal skeleton during times of calcium stress.

3) Pregnancy/lactation context

• Pregnancy and lactation cause profound maternal calcium stress.

4) Fetal vs maternal levels

• Fetal calcitonin levels are at least twofold higher than maternal levels.

5) Maternal calcitonin pattern

• Maternal calcitonin levels fall during pregnancy.
• Generally rise postpartum.

6) What increases calcitonin secretion

• Calcium and magnesium promote calcitonin biosynthesis and secretion.
• Gastric hormones also increase calcitonin levels:
• gastrin
• pentagastrin
• glucagon
• pancreozymin
• Food ingestion also promotes calcitonin plasma levels.

4) ADRENAL GLANDS

A. Cortisol

1) Morphology

• Maternal adrenal glands undergo little, if any, morphological change in normal pregnancy (unlike fetal adrenals).

2) Total cortisol rises, but binding explains it

• Serum circulating cortisol concentration rises.
• Much of it is bound to transcortin (cortisol-binding globulin).

3) Secretion rate

• Adrenal secretion rate of cortisol is not elevated.
• Probably lower than in the nonpregnant state.

4) Why cortisol levels still rise (clearance logic)

• Metabolic clearance rate of cortisol is diminished.
• Half-life is nearly doubled compared with nonpregnant women.

5) Estrogen effect comparison

• Estrogen administration (including most oral contraceptives) causes changes in serum cortisol and transcortin similar to pregnancy.

6) ACTH–free cortisol paradox across pregnancy

• Early pregnancy: ACTH (corticotropin) levels are dramatically reduced.
• As pregnancy progresses:
• ACTH rises strikingly
• free cortisol rises equally and strikingly
• This paradox is not completely understood.

7) Proposed explanations for higher free cortisol

• Resetting of maternal feedback mechanism to higher thresholds → possibly due to tissue refractoriness to cortisol.
• Another view: incongruities stem from progesterone antagonism of mineralocorticoids → elevated free cortisol needed to maintain homeostasis in response to high progesterone.
• Other theories: higher free cortisol prepares for stress of pregnancy, delivery, and lactation.

B. Aldosterone

1) When it increases

• As early as 15 weeks: maternal adrenal secretion of aldosterone increases considerably.

2) How much by 3rd trimester

• About 1 mg/day is released by 3rd trimester.

3) Sodium restriction effect

• If sodium intake is restricted, aldosterone secretion increases even more.

4) RAAS logic chain

• Renin levels rise.
• Angiotensin II substrate rises.
• Especially in latter half of pregnancy.
• → Plasma angiotensin II increases.
• Angiotensin II acts on zona glomerulosa.
• → Accounts for markedly elevated aldosterone secretion.

5) Proposed protective purpose

• Increased aldosterone may protect against natriuretic effects of:
• progesterone
• atrial natriuretic peptide (ANP)

6) Placental biology link

• Evidence suggests aldosterone and cortisol may modulate:
• trophoblast growth
• placental size

C. Deoxycorticosterone (DOC)

1) Pattern and magnitude

• Maternal plasma levels progressively increase.
• By term: ~1500 pg/mL.
• This is >15-fold increase.

2) Source is NOT adrenal

• Marked elevation is not from adrenal secretion.
• It reflects increased kidney production due to estrogen stimulation.

3) Fetal contribution hint

• Fetal blood levels of DOC and its sulfate are appreciably higher than maternal levels.
• Suggests transfer of fetal DOC into maternal compartment.

D. Androgens

1) Overall androgenic activity

• In balance, androgenic activity rises during pregnancy.
• Maternal plasma levels increase for:
• androstenedione
• testosterone

2) Not explained only by clearance

• This rise is not totally explained by metabolic clearance changes.

3) Placental conversion increases clearance (opposite force)

• Placenta converts androgens to estradiol → increases androgen clearance.

4) SHBG slows clearance (counter-force)

• Increased sex hormone–binding globulin (SHBG) in pregnancy retards testosterone clearance.

5) Net conclusion

• Production rates of maternal testosterone and androstenedione are increased.

6) Likely source

• Source of increased C19 steroid production is unknown.
• Likely originates in the ovary.

7) Why fetus doesn’t get maternal testosterone (key protection)

• Little or no maternal testosterone enters fetal circulation as testosterone.
• Even with massive maternal testosterone (e.g., androgen-secreting tumors):
• testosterone in umbilical cord blood is likely undetectable.
• Reason: near-complete trophoblastic conversion of testosterone to 17β-estradiol.

8) DHEA-S pattern

• Maternal serum and urine dehydroepiandrosterone sulfate levels are lower during normal pregnancy.
• Due to increased metabolic clearance via:
• extensive maternal hepatic 16α-hydroxylation
• placental conversion to estrogen

CENTRAL NERVOUS SYSTEM & RELATED CHANGES IN PREGNANCY — LOGIC NOTE (SECTION BY SECTION, ZERO OMISSION)

1) CENTRAL NERVOUS SYSTEM (GENERAL)

What changes overall?

• CNS changes during pregnancy are relatively few and mostly subtle.

Cerebral blood flow findings (objective imaging data)

• Zeeman et al. (2003) used MRI to measure cerebral blood flow across pregnancy.
• They found mean blood flow declined progressively in:
• Middle cerebral artery (MCA)
• Posterior cerebral artery (PCA)

Exact numbers (nonpregnant → late pregnancy)

• MCA: 147 mL/min → 118 mL/min
• PCA: 56 mL/min → 44 mL/min

Confirmation by another modality

• Others found similar MCA blood-flow changes using ultrasound (Batur Caglayan, 2019).

What causes it?

• Mechanisms and significance of this decline are unknown.

Key protective point

• Pregnancy appears not to affect cerebrovascular autoregulation (Cipolla, 2015).

2) MEMORY

What women commonly report

• Problems with:
• attention
• concentration
• memory
• Occurring throughout pregnancy and the early puerperium.

Strength of evidence

• Systematic memory studies in pregnancy are:
• limited
• often anecdotal

Meta-analysis summary (Davies et al., 2018)

• Pregnancy-related memory decline:
• was worst in the third trimester
• was not attributable to:
• depression
• anxiety
• sleep deprivation
• or other physical changes associated with pregnancy
• was transient
• quickly resolved after delivery

Important follow-up finding (disease effect)

• In follow-up studies:
• preeclampsia and eclampsia were found to lead to:
• short-term cognitive disability
• long-term cognitive disability

(Aukes, 2007; Dayan, 2018)

3) EYES

A. Intraocular pressure (IOP)

• IOP declines during pregnancy
• Attributed partly to greater vitreous outflow

B. Cornea changes (why contact lenses become uncomfortable)

• Corneal sensitivity decreases
• Greatest changes are late in gestation
• Most pregnant women show:
• a measurable but slight increase in corneal thickness
• thought due to edema
• Consequence:
• difficulty tolerating previously comfortable contact lenses

C. Pigmentation finding (Krukenberg spindles)

• Brownish-red opacities on the posterior corneal surface:
• Krukenberg spindles
• Seen with higher-than-expected frequency during pregnancy
• Mechanism proposed:
• hormonal effects similar to those producing skin lesions
• believed to cause this increased pigmentation

D. Visual function overall

• Other than transient loss of accommodation reported during:
• pregnancy
• lactation
• Visual function is unaffected by pregnancy

Literature note

• These pregnancy-related changes and pathological eye aberrations were reviewed by Gilbert et al. (2019).

4) SLEEP

When sleep disruption starts and ends

• Begins as early as 12 weeks’ gestation
• Extends through the first 2 months postpartum

The sleep pattern changes (what exactly happens)

Women have:

• difficulty falling asleep
• frequent awakenings
• fewer hours of night sleep
• reduced sleep efficiency

What this set of symptoms belongs to (pathway logic)

• These symptoms are part of the spectrum of sleep-disordered breathing
• The most severe form is obstructive sleep apnea

(Ayyar, 2018; Dominguez, 2018)

Peak disruption and mental health link

• Greatest disruption of sleep is encountered postpartum
• This may contribute to:
• postpartum blues
• frank depression
• suicidal ideation

(Palagini, 2019)

If you want, I can convert this into:

• a one-page “exam traps” sheet (MCA/PCA flow numbers + memory timing + eye changes + sleep-disordered breathing link),
• or Step-1 MCQs only (no answers) from this exact passage.